PT AU BA CA GP Z2 SO TI Z1 Z3

J Aaboud, Morad; Aad, Georges; Abbott, Brad; Abdinov,HEPData

O Table 12 Search for new high-mass phenomena in
J Aaboud, Morad; Aad, Georges; Abbott, Brad; Abdinov,HEPData
O Table 20 Search for top-squark pair production in fi
J Aaboud, Morad; Aad, Georges; Abbott, Brad; Abdinov,HEPData
O Table 67 Search for top-squark pair production in fi
J Aad, Georges; Abajyan, Tatevik; Abbott, Brad; AbdallaHEPData Table 1 Measurement of $\chi_{c1}$ and $\chi_{c2
J Aad, Georges; Abbott, Brad; Abdallah, Jalal; Abdelali HEPData Table 24 Measurement of the production cross sec
J Afshar, Baharak; Bibby, David F.; Piorkowska, Renata;JOURNAL A European multi-centre External Quality Assessm
J Akula, Hari K.; Kokatla, Hariprasad; Andrei, Graciela; ORGANIC Facile functionalization at the C4 position of pyrimid
J Aleksei Golubev, V.; Alexey Kubasov, S.; Alexander ByInorg. Che Synthesis of Perchlorinated Sulfonium Derivatives
J Andrei, G; van den Oord, J; Fiten, P; Opdenakker, G; ANTIMICROrganotypic epithelial raft cultures as a model for e
J Andrei, G; Sienaert, R; McGuigan, C; De Clercq, E; BalANTIMICRSusceptibilities of several clinical Varicella-zoster v
J Andrei, G; Snoeck, R; Vandeputte, M; DeClercq, E ANTIMICRActivities of various compounds against murine and
J ANDREI, G; SNOECK, R; DECLERCQ, E ANTIMICRSUSCEPTIBILITIES OF SEVERAL DRUG-RESIST
J Andrei, G.; Snoeck, R. Advances iAdvances in the Treatment of Varicella-Zoster Viru
J ANDREI, G; SNOECK, R; DECLERCQ, E ANTIVIRA HUMAN BRAIN-TUMOR CELL-LINES AS CELL SU
J Andrei, G; Fiten, P; De Clercq, E; Snoeck, R; OpdenakMETHODSMonitoring drug resistance for herpesviruses
J Andrei, G.; Topalis, D.; De Schutter, T.; Snoeck, R. ANTIVIRA Insights into the mechanism of action of cidofovir a
J Andrei, G.; Duraffour, S.; Van den Oord, J.; Snoeck, RANTIVIRA Epithelial raft cultures for investigations of virus gro
J Andrei, G; De Clercq, E; Snoeck, R ANTIVIRA In vitro selection of drug-resistant varicella-zoster v
J Andrei, G; Snoeck, R; Neyts, J; Sandvold, ML; Myhren,ANTIVIRA Antiviral activity of ganciclovir elaidic acid ester aga
J ANDREI, G; DECLERCQ, E ANTIVIRA MOLECULAR APPROACHES FOR THE TREATM
J ANDREI, G; DECLERCQ, E ANTIVIRA INHIBITORY EFFECT OF SELECTED ANTIVIRAL
J ANDREI, G; SNOECK, R; REYMEN, D; LIESNARD, CEUROPEAN COMPARATIVE ACTIVITY OF SELECTED ANTIV
J ANDREI, G; SNOECK, R; GOUBAU, P; DESMYTER, EUROPEAN COMPARATIVE ACTIVITY OF VARIOUS COMPO
J ANDREI, G; SNOECK, R; SCHOLS, D; GOUBAU, P; EUROPEAN COMPARATIVE ACTIVITY OF SELECTED ANTIV
J Andrei, G. Front. VirolVaccines and Antivirals: Grand Challenges and Gre
J Andrei, G. Front. VirolVaccines and antivirals: grand challenges and grea
J Andrei, G. Frontiers i Vaccines and antivirals: Grand challenges and grea
J Andrei, G.; Tiago Silva, d.S.; Milene, S.S. HICSS Artifacts for agile user-centered design: a systemat
J Andrei, G.; Frederick, H. R. IEEE Microw. Mag
J Andrei, G; Snoeck, R; De Clercq, E; Esnouf, R; Fiten, JOURNAL Resistance of herpes simplex virus type 1 against d
J Andrei, G; Dima, D; Andrei, L JOURNAL Lightweight magnetic composites for aircraft applic
J Andrei, G.; Topalis, D.; Fiten, P.; McGuigan, C.; Balza JOURNAL In Vitro-Selected Drug-Resistant Varicella-Zoster V
J Andrei, G; Balzarini, J; Fiten, P; De Clercq, E; Opden JOURNAL Characterization of herpes simplex virus type 1 thy
J Andrei, G.; Snoeck, R.; Pfaller, MA.; Grayson, ML. Kucers' theCidofovir
J Andrei, G; Snoeck, R; Schols, D; De Clercq, E ONCOLOGInduction of apoptosis by cidofovir in human papillo
J Andrei, G; Snoeck, R; Piette, J; Delvenne, P; De ClercONCOLOGAntiproliferative effects of acyclic nucleoside phosp
J Andrei, G; Snoeck, R; Piette, J; Delvenne, P; De ClercONCOLOGInhibiting effects of cidofovir (HPMPC) on the grow
J Andrei, G. RF and Microwave Transistor Oscillator Design
J Andrei, G. RF and Microwave Transmitter Design
J Andrei, G.; Fiten, P.; Goubau, P.; van Landuyt, H.; GorTRANSPLADual infection with polyomavirus BK and acyclovir-
J Andrei, G; Snoeck ADV TREATMENT VARICE
J Andrei, G. P ARMMS Highly-efficacy multistage Doherty architecture bas
J Andrei, G. P 24 EUR Advanced face gear technology for rotorcraft drive
J Andrei, G.; Pakhomov, D.; Miklavcic, M.S.M. ADV ELECAdvanced Electroporation Techniques in Biology a
J Andrei, G.A.; Koenig, R.; Kackmeister, S. Creating creativity-101 definitions (What Webster never told y
J ANDREI G M; COTO C E; DE TORRES R A Revista ArgANTIVIRAL ACTIVITY AND CYTOTOXICITY ASSA
J Andrei, Gabriel; Dima, Dumitru; Birsan, Iulian; Andrei, MATERIALEffect of Ferrite Particles on Mechanical Behaviour
J Andrei, Gabriel Nicolae; Constantinescu, Gabriel; NedeCHIRURGIAuspicious Management of a Acute Obstructive Le
J Andrei, Gabriel Nicolae; Popa, Bogdan; Gulie, LaurentCHIRURGIHighlighted Steps of the Management Algorithm in
J Andrei, Gabriela; Peptu, Catalina A.; Popa, Marcel; DeINTERNATFormulation and evaluation of cefuroxim loaded su
J Andrei, Gabriela Travaux duArnold Luciean Montandon (1852-1922): Bibliograp
J Andrei, Gabriela Travaux duDr. Igor L. Sienkiewicz (1907-2006).
J Andrei, Gavrilov; Marlen, BergaliyIEEE Internatio Industrial Messaging Middleware: Standards and P
J Andrei, Gaz Serban; Andrei, Boda Francisc; Roxana, MINI-REV Imidazole Derivatives and their Antibacterial Activit
J Andrei Georgios, E; Daniel, H LANG VIS WORKSH
J ANDREI, GM; DAMONTE, EB; DETORRES, RA; COTANTIVIRA INDUCTION OF A REFRACTORY STATE TO VIR
J ANDREI, GM; LAMPURI, JS; COTO, CE; DETORRESEXPERIENAN ANTIVIRAL FACTOR FROM MELIA-AZEDARA
J ANDREI, GM; COULOMBIE, FC; COURREGES, MC; JOURNAL MELIACINE, AN ANTIVIRAL COMPOUND FROM
J Andrei, Goncalves; Leonard, Gregory University The Fundamental-to-Market Ratio and the Value P
J Andrei, Gornykh Athena Organizing Fantasies: The Ideology of Late Capital
J Andrei, Graciela; Van Loon, Elisabet; Lerut, Evelyne; ANTIVIRA Persistent primary cytomegalovirus infection in a ki
J Andrei, Graciela; Carter, Kara; Janeba, Zlatko; SampaANTIVIRA Highlights of the 30th International Conference on
J Andrei, Graciela ANTIVIRA Three-dimensional culture models for human viral d
J Andrei, Graciela; Fiten, Pierre; Froeyen, Matheus; De ANTIVIRA DNA polymerase mutations in drug-resistant herpe
J Andrei, Graciela; Fiten, Pierre; Krecmerova, Marcela; BIOMEDICPoxviruses Bearing DNA Polymerase Mutations Sh
J Andrei, Graciela; Lisco, Andrea; Vanpouille, Christoph CELL HOSTopical Tenofovir, a Microbicide Effective against H
J Andrei Graciela; Snoeck Robert; Schols D 文逸宁; 袁伟媛 Chinese JoSynthesis an 中国药物化学杂志
1,2,3-三氮唑类化合物的合成及抗病毒活
J Andrei, Graciela; Snoeck, Robert CURRENTKaposi's sarcoma-associated herpesvirus: the role
J Andrei, Graciela; Snoeck, Robert CURRENTHerpes simplex virus drug-resistance: new mutatio
J Andrei, Graciela; De Clercq, Eric; Snoeck, Robert CURRENTNovel inhibitors of human CMV
J Andrei, Graciela; Snoeck, Robert EXPERT OEmerging drugs for varicella-zoster virus infections
J Andrei, Graciela; Gillemot, Sarah; Topalis, Dimitrios; JOURNAL The Anti-Human Immunodeficiency Virus Drug Ten
J Andrei, Graciela; Georgala, Aspasia; Topalis, Dimitri; JOURNAL Heterogeneity and Evolution of Thymidine Kinase a
J Andrei, Graciela; Gammon, Don B.; Fiten, Pierre; De CJOURNAL Cidofovir resistance in vaccinia virus is linked to dim
J Andrei, Graciela; Snoeck, Robert MOLECULAdvances and Perspectives in the Management of
J Andrei, Graciela; Trompet, Erika; Snoeck, Robert MOLECULNovel Therapeutics for Epstein-Barr Virus
J Andrei, Graciela; De Clercq, Erik; Snoeck, Robert VIRAL GE Viral DNA Polymerase Inhibitors
J Andrei, Graciela; Snoeck, Robert VIRUSES-Cidofovir Activity against Poxvirus Infections
J Andrei, Graciella; De Clercq, Erik; Snoeck, Robert Infectious Drug Targets in Cytomegalovirus Infection
J Andrei, Gritsenko Klymenko Glava Instituta demografii Ukrainy Ella Libanova: S
J Andrei (Guriencu), Raluca C.; Cristea, Victor; Cretu, AACL BioflThe effect of temperature on the standard and rout
J Andrei, L; Andrei, G. ANALYSIS OF GEAR QUALITY CRITERIA AND PERFORMA
J Andrei, L; Andrei, G; Epureanu, A; Oancea, N; WaltonINTERNATNumerical simulation and generation of curved face
J Andrei, L.; Walton, D.; Andrei, G.; Mereuta, E. The AnnalsInfluence of a non-standard geometry of plastic gea
J Andrei, L.; Andrei, G.; Epureanu, A.; Birsan, I. G The AnnalsSynthesis and Analysis of Plastic Curved Facewidt
J Andrei, L.; Andrei, G.; Walton, D. 10 INT C Analysis of gear quality criteria and performance of
J Angell, A; McGuigan, C; Sevillano, LG; Snoeck, R; Andr BIOORGAN Bicyclic anti-VZV nucleosides: thieno analogues be
J Anisimov Andrei, G; Ronald, Beukema; Jason, Hwang;MultimodalAIRTuB: towards automated inspection of leading e
J [Anonymous] TRIBOL IND
J [Anonymous] ROMAN NEUROSURG
J Babic, Maja Stipkovic; Makuc, Damjan; Plavec, Janez;EUROPEANM Novel halogenated 3-deazapurine, 7-deazapurine a
J Babkov, D. A.; Paramonova, M. P.; Ozerov, A. A.; Khan ACTA NAT2-(2,4-Dioxy-1,2,3,4-Tetrahydropyrimidin-1-yl)-N-(4
J Babkov, Denis A.; Khandazhinskaya, Anastasia L.; Chiz BIOORGAN Toward the discovery of dual HCMV-VZV inhibitors
J Bacaita, Elena Simona; Bejinariu, Costica; Zoltan, BorJOURNAL Nonlinearities in Drug Release Process from Polym
J Bache, Manon; Andrei, Graciela; Bindl, Lutz; BofferdinJOURNAL Antiviral Drug-Resistance Typing Reveals Compart
J Baciarello, M; Montella, S; Andrei, G; Ceresini, MG; D Neuromodul International Neuromodulation Society's 13th World
J Balo, MC; Fernandez, F; Lens, E; Lopez, C; DeClercq,NUCLEOSISynthesis and antiviral activities of some novel carb
J Baluta, S.; Andrei, G. P INT C S Determining the Coordinates of a Hostile Gunfire b
J Balzarini, J; Stevens, M; Andrei, G; Snoeck, R; Strun HELVETICPridine oxide derivatives: Structure-activity relation
J Balzarini, J; Pannecouque, C; Naesens, L; Andrei, G; NUCLEOSI6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimi
J Balzarini, J.; Stevens, M.; Andrei, G.; Snoeck, R.; SowOrg. Chem. Front
J Balzarini, Jan; Andrei, Graciela; Balestra, Emanuela; PLOS PA A Multi-targeted Drug Candidate with Dual Anti-HIV
J Baraka, M.M.; Ibrahim, S.M.; Pannecouque, C.; Andrei,Eur. J. Med. Chem.
J Barbaric, M; Ursic, S; Pilepic, V; Zorc, B; Hergold-BrunJOURNAL Synthesis, X-ray crystal structure study, and cytost
J Bassani, R.; Ciulli, E.; Guiggiani, M.; Piccigallo, B.; An Proceedings
Elastohydrodynamic lubrication in face gears drives
J Bassani, R.; Ciulli, E.; Guiggiani, M.; Piccigallo, B.; An P INT TRI Elastohydrodynamic lubrication in face gears drives
J Bastiurea, M.; Rodeanu, M.S.; Dima, D.; Murarescu, M.Applied MeEvaluation of mechanical properties of polyester co
J Bastiurea, M; Dima, D; Andrei, G; Rodeanu, MS; CantaDig J NanoCorrelation between graphene oxide/graphite conte
J Bastiurea, M.; Rodeanu, M.; Andrei, G.; Dima, D.; CanDigest J. NCorrelation between graphene oxide/ graphite cont
J Bastiurea, M.; Rodeanu, M.; Dima, D.; Murarescu, M.; Digest J. NThermal and mechanical properties of polyester co
J Bastiurea, M.; Rodeanu, M. S.; Andrei, G.; Dima, D.; CDIGEST J CORRELATION BETWEEN GRAPHENE OXIDE /
J Bastiurea, M.; Rodeanu, M. S.; Dima, D.; Murarescu, MDIGEST J THERMAL AND MECHANICAL PROPERTIES OF
J Bastiurea, M.; Rodeanu Bastiurea, M.S.; Andrei, G.; DiTribol. Ind Determination of specific heat of polyester compos
J Bastiurea, M. S.; Bastiurea, M.; IEEE 2015 IEE Dynamic mechanical properties for polyester/micro
J Bastiurea, Marian; Dima, Dumitru; Andrei, Gabriel MATERIALEffect of Graphene Oxide and Graphite on Dry Slid
J Bastiurea, Marian; Dima, Dumitru; Hadar, Anton; AndreREVISTA DFriction and Wear Behaviour of Polyester Nanocom
J Baszczynski, O.; Kaiser, M. M.; Cesnek, M.; Brehova, P Antiviral Xanthine-Based Acyclic Nucleoside Phosphonates
J Baszczynski, Ondrej; Kaiser, Martin Maxmilian; CesnekAntiviral Xanthine-based acyclic nucleoside phosphonates w
J Bauters, Tiene; Bordon, Victoria; Florin, Lisa; Padalk ANTIVIRA Multidrug-resistant cytomegalovirus infection in a p
J Bergstrom, Donald E; Lin, Xiaoping; Wood, Troy D; WitAntiviral Polysulfonates derived from metal thiolate complex
J Besnea, A.; Trufasu, D.; Andrei, G.; Deleanu, L. MechanicalWear behaviour of polyphenylene sulphide compos
J Bessieres, Maxime; Sari, Ozkan; Roy, Vincent; Warszyck CHEMISTRSonication-Assisted Synthesis of (E)-2-Methyl-but-
J Bessieres, Maxime; Hervin, Vincent; Roy, Vincent; Char EUROPEAN Highly convergent synthesis and antiviral activity of
J Bidet, Olivier; McGuigan, Christopher; Snoeck, Robert;Antiviral Non-nucleoside structures retain full anti-HCMV po
J Bivacqua, Roberta; Barreca, Marilia; Spano, Virginia; EUROPEAN Insight into non-nucleoside triazole-based systems
J Blewett, S; McGuigan, C; Barucki, H; Andrei, G; Snoeck NUCLEOSIBicyclic furo pyrimidine nucleosides with aryloxyph
J Boons, Eline; Nogueira, Tatiane C.; Dierckx, Tim; Me BLOOD CAXPO1 inhibitors represent a novel therapeutic optio
J Boons, Eline; Vanstreels, Els; Jacquemyn, Maarten; EBIOMEDIHuman Exportin-1 is a Target for Combined Therap
J Borges, JER; Fernandez, F; Garcia, X; Hergueta, AR; N L UCLEOSINovel carbocyclic nucleosides containing a cyclobu
J Bray, Mike; Andrei, GrInt Soc Antiviral Res ANTIVIRA Meeting report: 31st International Conference on A
J Brisse, E.; Imbrechts, M.; Mitera, T.; Vandenhaute, J. CLINICAL Lymphocyte-independent pathways underlie the pa
J Brisse, E.; Wouters, C. H.; Andrei, G.; Matthys, P. Frontiers How viruses contribute to the pathogenesis of hem
J Brisse, Ellen; Wouters, Carine H.; Andrei, Graciela; MaFRONTIERHow Viruses Contribute to the Pathogenesis of Hem
J Brisse, Ellen; Imbrechts, Maya; Put, Karen; Avau, AnnJOURNAL Mouse Cytomegalovirus Infection in BALB/c Mice R
J Brisse, Ellen; Imbrechts, Maya; Mitera, Tania; VandenhVIROLOGYLytic viral replication and immunopathology in a cyt
J Broggi, Julie; Joubert, Nicolas; Aucagne, Vincent; BertNUCLEOSIAlkyne-azide click chemistry mediated carbanucleo
J Bughi, S; Aleotti, P; Bruschi, R; Andrei, G; Milani, G; SSlow movements of slopes interfering with pipelines: modellin
J Bughi, S.; Aleotti, P.; Bruschi, R.; Andrei, G.; Milani, G.P INT C Slow Movements of Slopes Interfering with Pipeline
J Carangio, A; Srinivasan, S; McGuigan, C; Andrei, G; Sn Antiviral Bicyclic nucleoside inhibitors of varicella-zoster viru
J Carangio, A; McGuigan, C; Andrei, G; Snoeck, R; De Cl NUCLEOSIBicyclic nucleoside inhibitors of Varicella-Zoster Vir
J Castro, S.D.; Lobaton, E.; Perez-Perez, M.J.; San-FelixJ. Med. Chem.
J Chandrasekaran, G.; Antoanela, N.; Andrei, G.; MonicaApplied ScVisual Sentiment Analysis Using Deep Learning Mo
J Chandrasekaran, Ganesh; Antoanela, Naaji; Andrei, APPLIED Visual Sentiment Analysis Using Deep Learning Mo
J Chaouni-Benabdallah, A; Galtier, C; Allouchi, H; Kher CHEMICAL3-benzamido, ureido and thioureidoimidazo[1,2-a]p
J CHEN, X; SCHNELLER, SW; IKEDA, S; SNOECK, R; JOURNAL SYNTHESIS AND ANTIVIRAL ACTIVITY OF 5'-DE
J Chevrier, F.; Chamas, Z.; Lequeux, T.; Pfund, E.; Andre RSC Adv Synthesis of 5,5-Difluoro-5-phosphono-pent-2-en-1
J Chirita, G.; Andrei, G.; Birsan, IG.; Dumitru, D.; CantarAnn. Dunarea Jos. Uni. Galati Fasc. Ix. Metal. Mater. Sci
J Chirita, G; Dima, D; Andrei, G; Birsan, IG Mater PlastMechanical Characterization of Graphite and Graph
J Chirita, G.; Dima, D.; Andrei, G.; Birsan, I Materiale PMechanical Characterization of Graphite and Graph
J Chirita, G; Dima, D; Andrei, G; Birsan, IG Matrix Mechanical Characterization of Graphite and Graph
J Cikla, Pelin; Kucukguzel, S. Guniz; Kucukguzel, Ilkay; MARMARASynthesis and evaluation of antiviral, antitubercular
J Circiumaru, Adrian; Andrei, Gabriel; Birsan, Iulian-Ga MATERIALElectrical Conductivity of Fabric Based Filled Epoxy
J Circiumaru, Adrian; Bria, Vasile; ASME PROCEEDISOME PROPERTIES OF STRATIFIED COMPOSI
J Ciupagea, L.; Andrei, G.; Dima, D.; Murarescu, M. DIGEST J SPECIFIC HEAT AND THERMAL EXPANSION OF
J Clercq, E.D.; Cools, M.; Balzarini, J.; Snoeck, R.; An Antimicrob. Agents Chemother
J Coen, N.; Singh, U.; Vuyyuru, V.; Van den Oord, J. J.; JB. Virol. Activity and Mechanism of Action of HDVD, a Nove
J Coen, N.; Singh, U.; Vuyyuru, V.; Van den Oord, J. J.; JBOURNAL Activity and Mechanism of Action of HDVD, a Nove
J Coen, Natacha; Duraffour, Sophie; Topalis, Dimitri; SnANTIMICRSpectrum of Activity and Mechanisms of Resistanc
J Coen, Natacha; Duraffour, Sophie; Haraguchi, Kazuhiro ANTIMICRAntiherpesvirus Activities of Two Novel 4 '-Thiothym
J Coen, Natacha; Duraffour, Sophie; Naesens, Lieve; KrJOURNAL Evaluation of Novel Acyclic Nucleoside Phosphona
J Coen, Natacha; Duraffour, Sophie; Snoeck, Robert; AnVIRUSES-KSHV Targeted Therapy: An Update on Inhibitors o
J Corcoran, P.; Andrei Gagarin, A. Multiple domination models for placement of electric vehicle c
J Cotet, A.; Bastiurea, M.; Andrei, G.; Cantaragiu, A.; HaChim Dry Sliding Friction Analysis and Wear Behavior of
J Cotet, Adrian; Bastiurea, Marian; Andrei, Gabriel; Can MATERIALMechanical And Thermal Behavior of Carbon Nano
J Cotet, Adrian; Bastiurea, Marian; Andrei, Gabriel; Can REVISTA DDry Sliding Friction Analysis and Wear Behavior of
J Cretu, Mirela; Dediu, Lorena; Docan, Angelica; Cristea,SCIENTIF EFFECTS OF FEEDING LEVELS ON GROWTH P
J Cristofoli, Walter A.; Wiebe, Leonard I.; De Clercq, Er JOURNAL 5-alkynyl analogs of arabinouridine and 2'-deoxyur
J Daelemans, Dirk; Boons, Eline; Vanstreels, Els; Jac BLOOD Selective Inhibitors of Nuclear Export (SINE) Comp
J Dal Pozzo, F; Andrei, G; Holy, A; Van Den Oord, J; Sca ANTIMICRActivities of acyclic nucleoside phosphonates again
J Dal Pozzo, Fabiana; Andrei, Graciela; Lebeau, Ilya; BeANTIVIRA In vitro evaluation of the anti-orf virus activity of a
J Dal Pozzo, Fabiana; Andrei, Graciela; Daelemans, DirkJOURNAL Fluorescence-based antiviral assay for the evaluati
J DAMONTE, E; NEYTS, J; PUJOL, CA; SNOECK, R; BIOCHEMIANTIVIRAL ACTIVITY OF A SULFATED POLYSA
J De Bolle, L; Andrei, G; Snoeck, R; Zhang, Y; Van LomBIOCHEMIPotent, selective and cell-mediated inhibition of hum
J de Castro, S; Lobaton, E; Perez-Perez, MJ; San-Felix,JOURNAL Novel [2 ',5 '-bis-O-(tert-butyldimethylsilyl)-beta-D-r
J de Castro, Sonia; Familiar, Olga; Andrei, Graciela; S CHEMMEDFrom beta-Amino-gamma-sultone to Unusual Bicyc
J De Castro, Sonia; Garcia-Aparicio, Carlos; Andrei, Gr JOURNAL 4-Benzyloxy-gamma-Sultone Derivatives: Discover
J De Castro, Sonia; Garcia-Aparicio, Carlos; Andrei, Gr JOURNAL 4-Benzyloxy-gamma-Sultone Derivatives: Discover
J de Castro, Sonia; Peromingo, M. Teresa; Naesens, LieJOURNAL 4 ''-Benzoylureido-TSAO derivatives as potent and
J De Castro, Sonia; Andrei, Graziela; Snoeck, Robert; BNUCLEOSINovel non-nucleoside human cytomegalovirus inhib
J De Clercq, E; Andrei, G; Balzarini, J; Leyssen, P; Na NUCLEOSIAntiviral potential of a new generation of acyclic nu
J De Clercq, E; Andrei, G; Snoeck, R; De Bolle, L; Naese NUCLEOSIAcyclic/carbocyclic guanosine analogues as anti-he
J De Clercq, E; Andrei, G; Balzarini, J; Hatse, S; Lieken NUCLEOSIAntitumor potential of acyclic nucleoside phosphon
J De Schutter, Tim; Andrei, Graciela; Topalis, Dimitri; BMC MEDICidofovir selectivity is based on the different respon
J De Schutter, Tim; Andrei, Graciela; Topalis, Dimitri; CANCER LCidofovir treatment improves the pathology caused
J De Schutter, Tim; Andrei, Graciela; Topalis, Dimitri; D MOLECULReduced tumorigenicity and pathogenicity of cervic
J DECLERCQ, E; COOLS, M; BALZARINI, J; SNOECK,ANTIMICRANTIVIRAL ACTIVITIES OF 5-ETHYNYL-1-BETA
J Degreve, B; Andrei, G; Izquierdo, M; Piette, J; Morin, GENE THEVaricella-zoster virus thymidine kinase gene and an
J Dejmek, M.; Klima, M.; Sala, M.; Hrebabecky, H.; DraciBioorg. MeNorbornane-based nucleoside and nucleotide anal
J Dejmek, Milan; Sala, Michal; Hrebabecky, Hubert; DracBIOORGAN Norbornane-based nucleoside and nucleotide anal
J Deleanu, L; Andrei, G; Maftei, L P ASME 20Surface characterization of polymer composite usin
J Deleanu, Lorena; Birsan, Iulian Gabriel; Andrei, Gabri MATERIALPTFE Composites and Water Lubrication. II. Surfac
J Deleanu, Lorena; Birsan, Iulian Gabriel; Andrei, Gabri MATERIALPTFE composites and water lubrication - I. Tribogic
J Derudas, Marco; Quintiliani, Maurizio; Brancale, AndreAntiviral Evaluation of novel phosphoramidate ProTides of t
J Derudas, Marco; McGuigan, Christopher; Brancale, Andr ANTIVIRA Design, synthesis and biological evaluation of nove
J Derudas, Marco; Vanpouille, Christophe; Carta, DavideJOURNAL Virtual Screening of Acyclovir Derivatives as Poten
J Di, Micco S.; Musella, S.; Sala, M.; Scala, MC.; AndreiInt J Mol SPeptide Derivatives of the Zonulin Inhibitor Larazot
J Di Micco, Simone; Rahimova, Rahila; Sala, Marina; Sca EUROPEAN Rational design of the zonulin inhibitor AT1001 der
J Di Micco, Simone; Musella, Simona; Sala, Marina; ScalINTERNATPeptide Derivatives of the Zonulin Inhibitor Larazot
J Di Sarno, Veronica; Lauro, Gianluigi; Musella, Simona EUROPEAN Identification of a dual acting SARS-CoV-2 proteas
J Diaconita, Alexandra; Andrei, Gabriel; Rusu, Liliana ENERGY New insights into the wind energy potential of the w
J Diaconita, Alexandra Ionelia; Andrei, Gabriel; Rusul, INVENTIOEstimation of the Tower Shape Effect on the Stress
J Diaconita, Alexandra Ionelia; Rusu, Liliana; Andrei, GaINVENTIOA Local Perspective on Wind Energy Potential in S
J Diez-Torrubia, Alberto; Balzarini, Jan; Andrei, Graci JOURNAL Dipeptidyl Peptidase IV Dependent Water-Soluble
J Dima, D; Andrei, G MATERIALInvestigation of the effect of Fe3O4 particles on the
J Dima, D.; Andrei, G. Romanian IJnteraction between ferrite particles and oxygen mo
J Dima, Dumitru; Murarescu, Monica; Andrei, Gabriel DIGEST J DISPERSION OF CARBON NANOTUBES COATE
J DING, L; GREHN, L; DECLERCQ, E; ANDREI, G; S ACTA CHESYNTHESIS AND ANTIVIRAL ACTIVITY OF 3 PY
J Dinh Ngoc, T.; Moons, N.; Kim, Y.; De Borggraeve, W.;Bioorg. MeSynthesis of triterpenoid triazine derivatives from a
J Dumitriu, B; Valcea, S; Andrei, G; Beuran, M J Clin Inve Evaluation of anemia as a postoperative risk factor
J Dumitriu, Bogdan; Valcea, Sebastian; Andrei, Gabriel; JOURNAL The impact of patient-dependent risk factors on mo
J Dumitru; Andrei, G.; Bastiurea; Rodeanu, M.S. An. Univ. "Dunarea Jos" Galati, Fasc. IX. Metall. Mat. Sci
J Duraffour, S.; Andrei, G.; Snoeck, R. VIROLOGINew therapeutic weapons against poxvirus
J Duraffour, Sophie; Drillien, Robert; Haraguchi, KazuhirANTIMICRKAY-2-41, a Novel Nucleoside Analogue Inhibitor o
J Duraffour, Sophie; Snoeck, Robert; Krecmerova, Marcel ANTIMICRActivities of several classes of acyclic nucleoside p
J Duraffour, Sophie; Meyer, Hermann; Andrei, Graciela; ANTIVIRA Camelpox virus
J Duraffour, Sophie; Snoeck, Robert; de Vos, Rita; van dANTIVIRA Activity of the anti-orthopoxvirus compound ST-246
J Duraffour, Sophie; Andrei, Graciela; Snoeck, Robert IDRUGS Tecovirimat, a p37 envelope protein inhibitor for the
J Duraffour, Sophie; Lorenzo, Maria M.; Zoeller, GudrunJOURNAL ST-246 is a key antiviral to inhibit the viral F13L ph
J Duraffour, Sophie; Andrei, Graciela; Topalis, Dimitri JOURNAL Mutations Conferring Resistance to Viral DNA Poly
J Duraffour, Sophie; Mertens, Barbara; Meyer, Hermann;PLOS ONEEmergence of Cowpox: Study of the Virulence of C
J Duraffour, Sophie; Matthys, Patrick; van den Oord, JooPLOS ONEStudy of Camelpox Virus Pathogenesis in Athymic
J Duroffour, Sophie; Vigne, Solenne; Vermeire, Kurt; GaANTIVIRA Specific targeting of the F13L protein by ST-246 af
J Dzimbeg, G.; Zorc, B.; Kralj, M.; Ester, K.; Pavelic, K.; EUROPEAN The novel primaquine derivatives of N-alkyl, cycloa
J El Mansouri, Az-eddine; Oubella, Ali; Danoun, Karim; ARCHIV DDiscovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4
J El Mansouri, Az-Eddine; Maatallah, Mohamed; BenhasNUCLEOSIDesign, synthesis, chemical characterization, biolo
J El-Sabbagh, Osama I.; Baraka, Mohamed M.; Ibrahim,EUROPEAN Synthesis and antiviral activity of new pyrazole and
J ELHAKMAOUI, A; GUEIFFIER, A; MILHAVET, JC; B BIOORGAN SYNTHESIS AND ANTIVIRAL ACTIVITY OF 3-SU
J Elkakmaoui, A; Gueiffier, A; Milhavet, J C; Blache, Y; Bioorg. MeSynthesis and antiviral activity of 3-substituted imid
J Fan, Xuesen; Feng, Dong; Qu, Yingying; Zhang, Xinying BIOORGAN Practical and efficient synthesis of pyrano[3,2-c]pyr
J Ferir, G.; Petrova, M. I.; Andrei, G.; Snoeck, R.; Brons BMC Infect. Dis
J Ferir, G.; Petrova, M.I.; Andrei, G.; Huskens, D.; Hoor PLoS The lantibiotic peptide labyrinthopeptin A1 demons
J Ferir, G; Petrova, MI; Andrei, G; Huskens, D; Hoorelb Rev AntivirLabyrinthopeptin A1, a novel lantibiotic peptide, is a
J Ferir, G.; Petrova, M. I.; Andrei, G.; Huskens, D.; Hoo The lantibiotic peptide labyrinthopeptin A1 demonstrates broa
J Ferir, Geoffrey; Petrova, Mariya I.; Andrei, Graciela PLOS ONEThe Lantibiotic Peptide Labyrinthopeptin A1 Demon
J Fern, G.; Petrova, M. I.; Andrei, G.; Huskens, D.; HoorPLoS One The lantibiotic peptide labyrinthopeptin Al demonst
J Figueira, MJ; Blanco, JM; Caamano, O; Fernandez, F;ARCHIV DSynthesis and antiviral and cytostatic activities of c
J Frey, Christian R.; Andrei, Graciela; Votruba, Ivan; ANTICANCMutations in Adenosine Deaminase-like (ADAL) Pr
J Galtier, Christophe; Mavel, Sylvie; Snoeck, Robert; AnAntiviral Synthesis and antiviral activities of 3-aralkylthiomet
J Gammon, Don B.; Duraffour, Sophie; Rozelle, Daniel K.; ELIFE A single vertebrate DNA virus protein disarms inve
J Gammon, Don B.; Snoeck, Robert; Fiten, Pierre; Krecme JOURNAL Mechanism of Antiviral Drug Resistance of Vaccini
J Gammon, Don B.; Gowrishankar, Branawan; Duraffour, PLOS PA Vaccinia Virus-Encoded Ribonucleotide Reductase
J Gazivoda, T.; Rai-Mali, S.; Kristafor, V.; Makuc, D.; Plav
BioorganicSynthesis, Cytostatic and anti-HIV Evaluations of th
J Gazivoda, Tatjana; Raic-Malic, Silvana; Kristafor, Ved BIOORGAN Synthesis, cytostatic and anti-HIV evaluations of th
J Gazivoda, Tatjana; Sokcevic, Mario; Kralj, Marijeta; SuJOURNAL Synthesis and antiviral and cytostatic evaluations o
J George, A.N.; Cristina, B.; Andrei, G.T.; Lucian, P.; AnSol. Energy
J Gerona-Navarro, G; de Vega, MJP; Garcia-Lopez, MT;BIOORGANA Synthesis and anti-HCMV activity of 1-acyl-beta-lac
J Gerona-Navarro, G; de Vega, MJP; Garcia-Lopez, MT;JOURNAL A From 1-acyl-beta-lactam human cytomegalovirus p
J Glowacka, Iwona E.; Gawron, Katarzyna; Piotrowska, Do ANTIVIRA Design and synthesis of a new series of hybrids of
J Glowacka, Iwona E.; Andrei, Graciela; Schols, Domin ARCHIV DDesign, Synthesis, and the Biological Evaluation of
J Glowacka, Iwona E.; Balzarini, Jan; Andrei, Graciela; BIOORGAN Design, synthesis, antiviral and cytostatic activity o
J Glowacka, Iwona E.; Grabkowska-Druzyc, Magdalena;INTERNATNovel
An N-Substituted 3-Aryl-4-(diethoxyphosphoryl)a
J Glowacka, Iwona E.; Gulej, Rafal; Grzonkowski, Piotr; MOLECULSynthesis and the Biological Activity of Phosphony
J Glowacka, Iwona E.; Andrei, Graciela; Schols, Domini MOLECULPhosphonylated Acyclic Guanosine Analogues with
J Glowacka, Iwona E.; Piotrowska, Dorota G.; Andrei, GMONATSHE Acyclic nucleoside phosphonates containing the am
J Glowacka, Iwona E.; Piotrowska, Dorota G.; Andrei, GMONATSHE Acyclic nucleoside phosphonates containing the am
J GOLANKIEWICZ, B; OSTROWSKI, T; ANDREI, G; S JOURNAL TRICYCLIC ANALOGS OF ACYCLOVIR AND GAN
J Gordts, Stephanie C.; Ferir, Geoffrey; D'huys, ThomasPLOS ONEThe Low-Cost Compound Lignosulfonic Acid (LA) E
J Gornykh, Andrei Dialog. Ka Bakhtin i poststrukturalistskii povorot
J Gowacka, I. E.; Gulej, R.; Grzonkowski, P.; Andrei, G.;Molecules
J Gowacka, I. E.; Andrei, G.; Snoeck, R.; Schols, D.; Pi Molecules
J Gowacka, I. E; Piotrowska, D. G; Andrei, G; Schols, D Monatsh. Chem.
J Gowacka, IE; Piotrowska, DG; Andrei, G; Schols, D; Monatsh Chem
J Grabkowska-Druzyc, Magdalena; Andrei, Graciela; SchMOLECULIsoxazolidine Conjugates of N3-Substituted 6-Brom
J Gueiffier, A; Mavel, S; Lhassani, M; Elhakmaoui, A; SnJOURNAL Synthesis of imidazo[1,2-a]pyridines as antiviral ag
J Gueiffier, A; Lhassani, M; Elhakmaoui, A; Snoeck, R; JOURNAL Synthesis of acyclo-C-nucleosides in the imidazo[1
J Hagiwara, Akifumi; Yao, Jingwen; Raymond, Catalina; NEUROIMA
C "Aerobic glycolytic imaging" of human gliomas usin
J Hamada, Manabu; Roy, Vincent; McBrayer, Tamara R.; EUROPEAN
Wh Synthesis and broad spectrum antiviral evaluation
J Haraguchi, Kazuhiro; Kumamoto, Hiroki; Konno, Kiju; TETRAHE Synthesis of 4 '-substituted 2 '-deoxy-4 '-thiocytidin
J Harris, SA; McGuigan, C; Andrei, G; Snoeck, R; De Cler ANTIVIRA Synthesis and antiviral evaluation of phosphoramid
J Hartwich, Anna; Zdzienicka, Nee; Schols, Dominique; NUCLEOSIDesign, synthesis and antiviral evaluation of novel
J Hocek, M; Masojidkova, M; Holy, A; Andrei, G; Snoeck,COLLECTISynthesis and antiviral activity of acyclic nucleotide
J Hockova, D; Holy, A; Masojidkova, M; Andrei, G; Snoeck BIOORGAN Synthesis and antiviral activity of 2,4-diamino-5-cy
J Hockova, D; Holy, A; Masojidkova, M; Andrei, G; Snoeck JOURNAL 5-Substituted-2,4-diamino-6-[2-(phosphonomethox
J Hockova, Dana; Holy, Antonin; Andrei, Graciela; SnoecBIOORGAN Acyclic nucleoside phosphonates with a branched
J Holy, A; Votruba, I; Masojidkova, M; Andrei, G; SnoeckJOURNAL 6-[2-(phosphonomethoxy)alkoxy]pyrimidines with a
J Holy, A; Gunter, J; Dvorakova, H; Masojidkova, M; Andr JOURNAL Structure-antiviral activity relationship in the series
J Holy, A; Dvorakova, H; Jindrich, J; Masojidkova, M; BuJOURNAL Acyclic nucleotide analogs derived from 8-azapurin
J Horejsi, Katefina; Andrei, Graciela; De Clercq, Erik; BIOORGAN Tricyclic etheno analogs of PMEG and PMEDAP: S
J Hulpia, F.; Noppen, S.; Schols, D.; Andrei, G.; SnoeckEur. J. Me Synthesis of 3'-C-ethynyl-- D-ribofuranose purine n
J Hulpia, Fabian; Balzarini, Jan; Schols, Dominique; An BIOORGAN Exploring the purine core of 3 '-C-ethynyladenosine
J Hulpia, Fabian; Noppen, Sam; Schols, Dominique; Andr EUROPEAN Synthesis of a 3 '-C-ethyny1-beta-D-ribofuranose p
J Iliu, V.; Rip, M.; Javorova, J.; Andrei, G. 13 INT C A comparative study on tribological behavior betwe
J Iliut, V.; R?pa, M.; Javorova, J.; Andrei, G. IOP C SERA comparative study on tribological behavior betwe
J Iliuta, V.; Ripa, M.; Javorova, J.; Andrei, G. IOP ConferA comparative study on tribological behavior betwe
J Iliuta, V.; Ripa, M.; Preda, A.; Andrei, G. Applied MeFriction and Wear Behavior of Moglice Polymer Co
J Iliuta, Virgil; Ripa, Minodora; Andrei, Gabriel; Preda, Applied MeProfilometric Evaluation of the Worn Surfaces unde
J Ionite, Andrei-Catalin; Rotariu, Mariana; Turnea, Alex BALNEO RHydrokinetotherapy combined with facilitation techn
J Ionite, Andrei-Catalin; Rotariu, Mariana; Turnea, Alex BALNEO RThe use of combined techniques: Scottish showers
J James, W.; Naoki, W.; Andrei, G. Microw. RFDoherty Amplifier Combines High Power and Efficie
J Janeba, Z; Balzarini, J; Andrei, G; Snoeck, R; De Cler JOURNAL Synthesis and biological evaluation of acyclic 3-[(2-
J Janeba, Zlatko; Holy, Antonin; Pohl, Radek; Snoeck, Ro CANADIANSynthesis and biological evaluation of acyclic nucle
J Janeba, Zlatko; Balzarini, Jan; Andrei, Graciela; SnoecCANADIANSynthesis and biological evaluation of 5-(alkyn-1-yl
J Kaczmarek, Renata; Twardy, Dylan J.; Olson, Trevor L.EUROPEAN Extension of furopyrimidine nucleosides with 5-alky
J Kaoukabi, Hanane; Kabri, Youssef; Curti, Christophe; EUROPEAN Dihydropyrimidinone/1,2,3-triazole hybrid molecule
J Karakus, Sevgi; Kucukguzel, S. Guniz; Kucukguzel, IlkEUROPEAN Synthesis, antiviral and anticancer activity of some
J Kaur, P. H.; Persoons, L.; Andrei, G.; Singh, K. ChemMed Quinoline-Dihydropyrimidin- 2(1H)-one Hybrids: Sy
J Kazsoki, Adrienn; Palcso, Barnabas; Alpar, Alan; SnoeINTERNATFormulation of acyclovir (core)-dexpanthenol (shea
J Kezin, Vasily A.; Matyugina, Elena S.; Novikov, Mikha MOLECULNew Derivatives of 5-Substituted Uracils: Potential
J Khaliliardali, Zahra; Chavarriaga IEEE IEEE EnginDetection of Anticipatory Brain Potentials during Ca
J Khandaker, T. A.; Hess, J. D.; Aguilera, R.; Andrei, G Eur. J. Med. Chem
J Khandaker, Tashrique A.; Hess, Jessica D.; Aguilera EUROPEAN Synthesis and Evaluations of "1,4-Triazolyl Combre
J Kokosza, Kamil; Andrei, Graciela; Schols, Dominique; BIOORGAN Design, antiviral and cytostatic properties of isoxaz
J Kollatos, Nikolaos; Mitsos, Christos; Manta, Stella; Tz MEDICINADesign, Synthesis, and Biological Evaluation of No
J Kolocouris, A; Dimas, K; Pannecouque, C; Witvrouw, M; BIOORGAN New 2-(1-adamantylcarbonyl)pyridine and 1-acetyl
J Kolocouris, N; Kolocouris, A; Foscolos, GB; Fytas, G; JOURNAL Synthesis and antiviral activity evaluation of some n
J Kowalczyk, Chris; Aguilera, Shino Bay; Andrei, GherghFACIAL P Face-off: Social Media Responsibility in Medicine a
J Kozlovskaya, Liubov, I; Andrei, Graciela; Orlov, Alexe ANTIVIRA Antiviral activity spectrum of phenoxazine nucleosid
J Kozlovskaya, Liubov, I; Volok, Viktor P.; Shtro, Anna EUROPEAN Phenoxazine nucleoside derivatives with a multiple
J Krecmerova, Marcela; Dracinsky, Martin; Snoeck, Robert BIOORGAN New prodrugs of two pyrimidine acyclic nucleoside
J Krecmerova, Marcela; Pohl, Radek; Masojidkova, Milena BIOORGAN N-4-Acyl derivatives as lipophilic prodrugs of cidofo
J Krecmerova, Marcela; Holy, Antonin; Andrei, Graciela;JOURNAL Synthesis of Ester Prodrugs of 9-(S)-[3-Hydroxy-2-
J Krecmerova, Marcela; Holy, Antonin; Pohl, Radek; Maso JOURNAL Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosph
J Krecmerova, Marcela; Holy, Antonin; Piskala, Alois; MaJOURNAL Antiviral activity of triazine analogues of 1-(S)-[3-h
J Krizhanovski, V. G.; Chernov, D.IEEE 2018 14T Low-Voltage Class E/F-3 High Frequency Oscillato
J Kumamoto, Hiroki; Topalis, Dimitri; Broggi, Julie; Pra TETRAHE Preparation of acyclo nucleoside phosphonate ana
J Lachhab, Saida; El Mansouri, Az-eddine; Mehdi, Ahmad MOLECULA Synthesis of new 3-acetyl-1,3,4-oxadiazolines com
J Lakatosh, SA; Balzarini, J; Andrei, G; Snoeck, R; De JOURNAL Synthesis, and cytotoxic activity of N-ind-alkoxy de
J Lakshman, Mahesh K.; Kumar, Amit; Balachandran, Ragh JOURNAL Synthesis and Biological Properties of C-2 Triazoly
J Lebeau, I.; Andrei, G.; Pozzo, F.D.; Beadle, J.R.; HostAntimicrobActivities of alkoxyalkyl esters of cidofovir (CDV), c
J Lebeau, Ilya; Andrei, Graciela; Krecmerova, Marcela; ANTIMICRInhibitory activities of three classes of acyclic nucle
J Lebeau, Ilya; Andrei, Graciela; Dal Pozzo, Fabiana; BeANTIMICRActivities of alkoxvalkyl esters of cidofovir (CDV), c
J Lebrun, Marielle; Lambert, Julien; Riva, Laura; Thele JOURNAL Varicella-Zoster Virus ORF9p Binding to Cellular A
J Leydet, A; Moullet, C; Roque, JP; Witvrouw, M; Pannec JOURNAL Polyanion inhibitors of HIV and other viruses. 7. Po
J Leydet, A; Barragan, V; Boyer, B; Montero, JL; Roque,JOURNAL Polyanion inhibitors of human immunodeficiency vi
J Leydet, A; JeantetSegonds, C; Bouchitte, C; Moullet, JOURNAL Polyanion inhibitors of human immunodeficiency vi
J Leydet, A; ElHachemi, H; Boyer, B; Lamaty, G; Roque,JOURNAL Polyanion inhibitors of human immunodeficiency vi
J LEYDET, A; BARTHELEMY, P; BOYER, B; LAMATY, JGOURNAL POLYANION INHIBITORS OF HUMAN-IMMUNOD
J Lhassani, M; Chavignon, O; Chezal, JM; Teulade, JC; EUROPEAN
Ch Synthesis and antiviral activity of imidazo[1,2-a]pyr
J Li, L.; Mario, Z.; Min, X.; Zhonghui, L.; Shanshan, W.; Nano Lett et al., Nanooptics of plasmonic nanomatryoshkas:
J Liekens, S; Andrei, G; Vandeputte, M; De Clercq, E; Ne CANCER Potent inhibition of hemangioma formation in rats b
J Lopez, Alan Daniel; Andrei, Guerrero Rene Ser MigranEl dilema de migrar en caravana: sobrevivir o ser v
J Luca, F.-A.; Ciobanu, C.-I.; Andrei, G. A.; Horodnic, V.SustainabilRaising awareness on health impact of the chemica
J Luo, Min; Groaz, Elisabetta; Snoeck, Robert; Andrei, GACS MEDIAmidate Prodrugs of O-2-Alkylated Pyrimidine Acy
J Luo, Min; Groaz, Elisabetta; De Jonghe, Steven; Snoec ACS MEDIAmidate Prodrugs of Cyclic 9-(S)-[3-Hydroxy-2(pho
J Luo, Min; Groaz, Elisabetta; Andrei, Graciela; Snoeck,JOURNAL Expanding the Antiviral Spectrum of 3-Fluoro-2-(ph
J Luoni, G; McGuigan, C; Andrei, G; Snoeck, R; De Clercq BIOORGAN Bicyclic nucleoside inhibitors of Varicella-Zoster vir
J Luoni, G; McGuigan, C; Andrei, G; Snoeck, R; De Clercq NUCLEOSIBicyclic nucleoside inhibitors of Varicella-Zoster Vir
J Luoni, Giovanna M.; McGuigan, Christopher; Andrei, Gr Antiviral Bicyclic nucleoside inhibitors of varicelia-zoster viru
J Macan, Andrijana Mescic; Harej, Anja; Cazin, Ines; KloEUROPEAN Antitumor and antiviral activities of 4-substituted 1,2
J MAFTEI, L ; DELEANU, L ; ANDREI, G The AnnalsInfluence of Sliding Speed and Average Pressure i
J Mahapatra, Manojkumar; Kulandaivelu, Umasankar; Saik CHEMICALMethyl-2-arylidene hydrazinecarbodithioates: synth
J Maiti, Munmun; Persoons, Leentje; Andrei, Graciela; Sn CHEMMEDSynthesis and Anti-herpetic Activity of Phosphoram
J Malak, Pirtskhalava; Andrei, Gabrielian; Cruz, Phillip; Nucleic AcGrigolava maia, chubinidze mindia, gogoladze geo
J Mandic, Leo; Bencic, Patricia; Mlinaric-Majerski, Kata; ARCHIV DSubstituted adamantylphthalimides: Synthesis, ant
J Manolache, Alexandra Ionelia; Andrei, Gabriel; Rusu, LJOURNAL An Evaluation of the Efficiency of the Floating Sola
J Mansouri, A.E.E.; Oubella, A.; Da noun, K.; Ahmad, M.; Arch. PharDiscovery of novel furo [2,3-d]pyrimidin-2-one-1,3,4
J Marti-Carreras, Joan; Mineeva-Sangwo, Olga; Topalis,VIRUSES-BKTyper: Free Online Tool for Polyoma BK Virus V
J Martinez, A; Esteban, AI; Herrero, A; Ochoa, C; AndreiBIOORGAN Imidazothiadiazine dioxides: Synthesis and antivira
J Martinez, A; Gil, C; Perez, C; Castro, A; Prieto, C; Ote JOURNAL Nonnucleoside human cytomegalovirus inhibitors: S
J Martinez, A; Esteban, AI; Castro, A; Gil, C; Conde, S; JOURNAL Novel potential agents for human cytomegalovirus
J Maruyama, T; Kozai, S; Demizu, Y; Witvrouw, M; Panne CHEMICALSynthesis and anti-HIV-1 and Anti-RCMV activity o
J Maruyama, T; Sato, Y; Oto, Y; Takahashi, Y; Snoeck, CHEMICALSynthesis and antiviral activity of 6-chloropurine ara
J MARUYAMA, T; HANAI, Y; SATO, Y; SNOECK, R; ANCHEMICALSYNTHESIS AND ANTIVIRAL ACTIVITY OF CAR
J Maruyama, Tokumi; Kozai, Shigetada; Yamasaki, Tetsuo Antiviral Synthesis and antiviral activity of 1,3-disubstituted
J Maruyama, Tokumi; Demizu, Yosuke; Kozai, Shigetada; NUCLEOSIAntiviral activity of 3-(3,5-dimethylbenzyl)uracil deri
J Maslova, Anna A.; Matyugina, Elena S.; Snoeck, Robert MOLECULUracil-Containing Heterodimers of a New Type: Sy
J Mavel, S; Renou, JL; Galtier, C; Snoeck, R; Andrei, G;ARZNEIMISynthesis
B of imidazo[1,2-a] pyridine derivatives as
J Mavel, S; Renou, JL; Galtier, C; Allouchi, H; Snoeck, R; BIOORGAN Influence of 2-substituent on the activity of imidazo
J McGuigan, C; Brancale, A; Barucki, H; Srinivasan, S; Jo ANTIVIRA Furano pyrimidines as novel potent and selective a
J McGuigan, C; Brancale, A; Andrei, G; Snoeck, R; De Cle BIOORGAN Novel bicyclic furanopyrimidines with dual anti-VZV
J McGuigan, C; Brancale, A; Barucki, H; Srinivasan, S; JDRUGS OFFluorescent bicyclic furo pyrimidine deoxynucleosid
J McGuigan, C; Pathirana, RN; Snoeck, R; Andrei, G; DeJOURNAL Discovery of a new family of inhibitors of human cy
J McGuigan, C; Barucki, H; Blewett, S; Carangio, A; EricJOURNAL Highly potent and selective inhibition of varicella-zo
J McGuigan, C; Yarnold, CJ; Jones, G; Velazquez, S; Baru JOURNAL Potent and selective inhibition of varicella-zoster vi
J McGuigan, C; Barucki, H; Carangio, A; Blewett, S; SrinNUCLEOSINovel aryl substituted bicyclic furo nucleosides as e
J McGuigan, C. H.; Blewett, S.; Carangio, A.; Erichsen, JJ Med Chem
J McGuigan, Christopher; Derudas, Marco; Gonczy, Blanka; BIOORGAN ProTides of N-(3-(5-(2 '-deoxyuridine))prop-2-ynyl)o
J McGuigan, Christopher; Bidet, Olivier; Derudas, Marco;BIOORGAN Alkenyl substituted bicyclic nucleoside analogues r
J McGuigan, Christopher; Derudas, Marco; Quintiliani, Ma BIOORGAN 2 '-Fluorosugar analogues of the highly potent anti-
J McGuigan, Christopher; Derudas, Marco; Bugert, Joachi BIOORGAN Successful kinase bypass with new acyclovir phosp
J McGuigan, Christopher; Pathirana, Ranjith N.; Miglior JOURNAL Preclinical development of bicyclic nucleoside anal
J Mei Macan, A.; Harej, A.; Cazin, I.; Klobuar, M.; StepaniEur. J. Me Antitumor and antiviral activities of 4-substituted 1,2
J MELGUIZO, M; SANCHEZ, A; NOGUERAS, M; LOW, TETRAHE FACILE PREPARATION OF 9H-PYRIMIDO[4,5-B]
J Mertens, Barbara; Cristina de Araujo Nogueira, TatianeOncotargetInvestigation of tumor-tumor interactions in a doubl
J Mertens, Barbara; Nogueira, Tatiane; Stranska, RuzenONCOTARCidofovir is active against human papillomavirus po
J Migliore, Marco D.; Zonta, Nicola; McGuigan, ChristophJOURNAL Synthesis and antiviral activity of the carbocyclic an
J Milica, Lucian; Nastase, Alexandru; Andrei, Gabriel MECHANISOptimal path planning for a new type of 6(R)under-
J Milica, Lucian; Nastase, Alexandru; Andrei, Gabriel PROCEEDIA novel algorithm for the absorbed power estimatio
J Mineeva-Sangwo, Olga; Marti-Carreras, Joan; Cleender VIRUSES-Polyomavirus BK Genome Comparison Shows Hig
J Mohammed, Anber F.; Andrei, Graciela; Hayallah, AlaaBIOORGAN Synthesis and anti-HSV activity of tricyclic penciclo
J Montagu, Aurelien; Roy, Vincent; Balzarini, Jan; Snoeck EUROPEAN Synthesis of new C5-(1-substituted-1,2,3-triazol-4 o
J du patrimoiLa collection d'heteropteres
J Morlin, F; Snoeck, R; Andrei, G; DeClercq, E ANTIVIRA Phenotypic resistance of herpes simplex virus type
J Murarescu, M.; Dima, D.; Andrei, G.; Circiumaru, A. DIGEST J SYNTHESIS OF POLYESTER COMPOSITES WIT
J Musella, S.; di Sarno, V.; Ciaglia, T.; Sala, M.; Spensi Eur. J. MedIdentification of an indol-based derivative as potent
J Musella, Simona; di Sarno, Veronica; Ciaglia, Tania; SEUROPEAN Identification of an indol-based derivative as potent
J Naesens, L; Lenaerts, L; Andrei, G; Snoeck, R; Van Bee ANTIMICRAntiadenovirus activities of several classes of nucle
J Naesens, L; Snoeck, R; Andrei, G; Balzarini, J; Neyts, ANTIVIRA HPMPC (cidofovir), PMEA (adefovir) and related ac
J Naesens, Lieve; Vanderlinden, Evelien; Roth, Erzsebet; ANTIVIRA Anti-influenza virus activity and structure-activity re
J Naesens, Lieve; Stephens, Chad E.; Andrei, Graciela; ANTIVIRA
L Antiviral properties of new arylsulfone derivatives w
J Naesens, Lieve; Andrei, Graciela; Votruba, Ivan; Krec BIOCHEMIIntracellular metabolism of the new antiviral compo
J Navarro, G. G.; de Vega, J. P.; Garcia-Lopez, M. T.; An Bioorg. Med. Chem. Lett.
J Navarro, GG; DeVega, MJP; Lopez, MTG; Andrei, G; Sn J. Med. C From 1-AScyl-a- lactam Human Cytomegalovirus P
J Neyts, J; Andrei, G; De Clercq, E ANTIMICRThe antiherpesvirus activity of H2G [(R)-9-[4-hydro
J Neyts, J; Andrei, G; De Clercq, E ANTIMICRThe novel immunosuppressive agent mycophenola
J NEYTS, J; JAHNE, G; ANDREI, G; SNOECK, R; WIN ANTIMICRIN-VIVO ANTIHERPESVIRUS ACTIVITY OF N-7-S
J NEYTS, J; ANDREI, G; SNOECK, R; JAHNE, G; WIN ANTIMICRTHE N-7-SUBSTITUTED ACYCLIC NUCLEOSIDE
J NEYTS, J; REYMEN, D; LETOURNEUR, D; JOZEFONV BIOCHEMIDIFFERENTIAL ANTIVIRAL ACTIVITY OF DERIV
J Neyts, J; Balzarini, J; Andrei, G; Zhu, CY; Snoeck, R MOLECULIntracellular metabolism of the N7-substituted acyc
J Niculescu, B.M.; Andrei, G. E3S Web oFormation evaluation challenges in Pliocene gas-b
J Niculescu, B.M.; Andrei, G. GeophysiqPrincipal component analysis as a tool for enhance
J Niculescu, Bogdan Mihai; Andrei, Gina ACTA GEOApplication of electrical resistivity tomography for im
J Niculescu, Bogdan Mihai; Andrei, Gina ACTA GEOUsing Vertical Electrical Soundings to characterize
J Novikov, Mikhail S.; Babkov, Denis A.; Paramonova, Ma BIOORGAN Synthesis and anti-HCMV activity of 1-[omega-(phe
J Novikov, Mikhail S.; Valuev-Elliston, Vladimir T.; Ba BIOORGAN N-1,N-3-disubstituted uracils as nonnucleoside inhi
J Nys, Kris; Maes, Hannelore; Andrei, Graciela; Snoeck,FREE RADSkin mild hypoxia enhances killing of UVB-damage
J Obara, T; Shuto, S; Saito, Y; Snoeck, R; Andrei, G; BaJOURNAL New neplanocin analogues .7. Synthesis and antiv
J Opacic, N; Barbaric, M; Zorc, B; Cetina, M; Nagy, A; FrJOURNAL The novel L- and D-Amino acid derivatives of hydro
J Ostrowski, Tomasz; Golankiewicz, Bozenna; De Clercq, EUROPEAN Synthesis and anti-VZV activity of 6-heteroaryl deri
J Otmar, Miroslav; Dracinsky, Martin; Krecmerova, Marcel HETEROCSYNTHESIS OF O-2- AND N-3-(2-PHOSPHONOM
J Ouahrouch, Abdelaaziz; Taourirte, Moha; Schols, DomiARCHIV DDesign, Synthesis, and Antiviral Activity of Novel R
J Pagano, Joseph S.; Whitehurst, Christopher B.; AndreiCANCERSAntiviral Drugs for EBV
J Papadakis, Georgios; Gerasi, Maria; Snoeck, Robert; Ma MOLECULSynthesis of New Imidazopyridine Nucleoside Deri
J Paramonova, M. P.; Khandazhinskaya, A. L.; Ozerov, A. ACTA NATSynthesis and Antiviral Properties of 1-Substituted
J Paramonova, Maria P.; Snoeck, Robert; Andrei, GracieMENDELEE New acetamide derivatives containing (omega-p-br
J Paramonova, Maria P.; Ozerov, Alexander A.; Chizhov,MENDELEE Synthesis of uracil-coumarin conjugates as potentia
J Parsons, B.N.; Walton, D.; Andrei, L.; Andrei, G. Gear TechnNon-standard cylindrical gears
J Patel, Jigarkumar; Malani, Mahesh; Andrei, Graciela; BAnti-Infect An Efficient Synthesis and Antiviral Activity Evaluat
J PATIL, SD; SCHNELLER, SW; HOSOYA, M; SNOECK, JOURNAL SYNTHESIS AND ANTIVIRAL PROPERTIES OF (
J Perez-Faginas, Paula; Teresa Aranda, M.; Teresa Garci BIOORGAN Synthesis and SAR studies on azetidine-containing
J Pertusati, Fabrizio; Serafini, Sara; Albadry, Najmiyah; ANTIVIRA Phosphonoamidate prodrugs of C5-substituted pyr
J Pileggi, Elisa; Serpi, Michaela; Andrei, Graciela; Scho BIOORGAN Expedient synthesis and biological evaluation of al
J Piotrowska, Dorota G.; Wroblewski, Andrzej E.; BalzarACTA POLSYNTHESIS AND BIOLOGICAL ACTIVITY OF NO
J Piotrowska, Dorota G.; Andrei, Graciela; Schols, Do EUROPEAN Synthesis, anti-varicella-zoster virus and anti-cytom
J Piotrowska, Dorota G.; Glowacka, Iwona E.; Schols, DMOLECULNovel Isoxazolidine and gamma-Lactam Analogues
J Piotrowska, Dorota G.; Andrei, Graciela; Schols, Do MOLECULNew Isoxazolidine-Conjugates of QuinazolinonesS
J Piotrowska, Dorota G.; Balzarini, Jan; Andrei, Gracie TETRAHE Novel isoxazolidine analogues of homonucleosides
J Plebanek, Elzbieta; Lescrinier, Eveline; Andrei, Graci EUROPEAN Emimycin and its nucleoside derivatives: Synthesis
J Pomeisl, Karel; Pohl, Radek; Snoeck, Robert; Andrei, NUCLEOSIUtilization of 1,3-Dioxolanes in the Synthesis of alp
J Pomeisl, Karel; Krecmerova, Marcela; Pohl, Radek; SnTETRAHE Synthesis of fluorinated acyclic nucleoside phospho
J Pradere, Ugo; Roy, Vincent; Montagu, Aurelien; Sari, EUROPEAN Synthesis and antiviral evaluation of bis(POM) prod
J Prekupec, Svjetlana; Makuc, Damjan; Plavec, Janez; Kral Antiviral Antiviral and cytostatic evaluation of the novel 6-ac
J Pruna, V; Bucur, N; Neacsu, A; Voina, A; Andrei, G; S Rom NeuroCalcified chronic subdural hematoma: case report
J Quintiliani, Maurizio; Persoons, Leentje; Solaroli, Nic BIOORGAN Design, synthesis and biological evaluation of 2 '-d
J Radu, M. C.; Andrei, L.; Andrei, G. IOP ConferA perspective on gear meshing quality based on tra
J Rashad, Adel A.; El-Sabbagh, Osama I.; Baraka, MohaMEDICINADesign, synthesis and preliminary antiviral screenin
J Reymen, D; Witvrouw, M; Este, JA; Neyts, J; Schols, ANTIVIRA Mechanism of the antiviral activity of new aurintrica
J Robins, MJ; Miranda, K; Rajwanshi, VK; Peterson, MA;JOURNAL Nucleic acid related compounds. Part 131. Synthes
J Robins, Morris J.; Nowak, Ireneusz; Rajwanshi, Vivek K JOURNAL Synthesis and antiviral evaluation of 6-(Alkyl-hetero
J Rygielska-Tokarska, Dorota; Andrei, Graciela; Schols MONATSHE Synthesis, antiviral, cytotoxic and cytostatic evalua
J SAGI, G; OTVOS, L; IKEDA, S; ANDREI, G; SNOECKJOURNAL SYNTHESIS AND ANTIVIRAL ACTIVITIES OF 8-A
J Santana, L; Teijeira, M; Uriarte, E; Teran, C; Andrei, GNUCLEOSISynthesis and biological evaluation of 1,2-disubstit
J Sari, Ozkan; Roy, Vincent; Balzarini, Jan; Snoeck, Robe EUROPEAN Synthesis and antiviral evaluation of C5-substituted
J Scagliarini, A; Dal Pozzo, F; Gallina, L; Guercio, A; D VETERINAOvine skin organotypic cultures applied to the ex vi
J Schalkwijk, Hanna H.; Snoeck, Robert; Andrei, GracielBIOCHEMIAcyclovir resistance in herpes simplex viruses: Pre
J Schalkwijk, Hanna Helena; Gillemot, Sarah; Reynders,JOURNAL Heterogeneity and viral replication fitness of HSV-1
J Schepers, Kinda; Hernandez, Antonio; Andrei, GracielaJOURNAL Acyclovir-resistant herpes simplex encephalitis in a
J Schols, D.; De Ctercq, E.; Balzanni, J.; Baba, M.; Witv ANTIVIRA Sulphated polymers are potent and selective inhibi
J Shimada, Hisashi; Haraguchi, Kazuhiro; Hotta, Kumi; M BIOORGAN Synthesis of 3 ',4 '-difluoro-3 '-deoxyribonucleoside
J Shuto, S; Obara, T; Saito, Y; Andrei, G; Snoeck, R; D JOURNAL New neplanocin analogues .6. Synthesis and poten
J SHUTO, S; OBARA, T; TORIYA, M; HOSOYA, M; SNO JOURNAL NEW NEPLANOCIN ANALOGS .1. SYNTHESIS O
J SIDDIQI, SM; CHEN, X; SCHNELLER, SW; IKEDA, S;JOURNAL ANTIVIRAL ENANTIOMERIC PREFERENCE FOR
J Sienaert, R; Naesens, L; Brancale, A; Carangio, A; AnNUCLEOSIMetabolic and pharmacological characteristics of th
J Simonart, T; Boelaert, JR; Andrei, G; De Clercq, E; S GYNECOLIron withdrawal strategies fail to prevent the growth
J Simonart, T; Boelaert, JR; Mosselmans, R; Andrei, G; GYNECOLAnti proliferative and apoptotic effects of iron chela
J Simonart, T; Boelaert, JR; Andrei, G; Van Den Oord, INTERNATDesferrioxamine enhances aids-associated Kaposi
J Simonart, T; Noel, JC; Andrei, G; Parent, D; Van Voor INTERNATIron as a potential co-factor in the pathogenesis of
J Simonart, T; Degraef, C; Andrei, G; Mosselmans, R; HJOURNAL Iron chelators inhibit the growth and induce the apo
J Snoeck, R; Holy, A; Dewolf-Peeters, C; Van Den Oord,ANTIMICRAntivaccinia activities of acyclic nucleoside phosph
J SNOECK, R; ANDREI, G; BALZARINI, J; REYMEN, ANTIVIRA DIPYRIDAMOLE POTENTIATES THE ACTIVITY O
J Snoeck, R; Andrei, G; Bodaghi, B; Lagneaux, L; DaeleANTIVIRA 2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-
J SNOECK, R; ANDREI, G; NEYTS, J; SCHOLS, D; COANTIVIRA INHIBITORY ACTIVITY OF S-ADENOSYLHOMOC
J SNOECK, R; SCHOLS, D; ANDREI, G; NEYTS, J; D ANTIVIRA ANTIVIRAL ACTIVITY OF ANTICYTOMEGALOVIR
J SNOECK, R; ANDREI, G; GERARD, M; SILVERMAN, CLINICAL SUCCESSFUL TREATMENT OF PROGRESSIVE
J Snoeck, R; Andrei, G; De Clercq, E DRUGS Current pharmacological approaches to the therapy
J Snoeck, R; Andrei, G; DeClercq, E EUROPEAN Patterns of resistance and sensitivity to antiviral co
J SNOECK, R; ANDREI, G; SCHOLS, D; BALZARINI, J EUROPEAN ACTIVITY OF DIFFERENT ANTIVIRAL DRUG-CO
J SNOECK, R; ANDREI, G; DECLERCQ, E INTERNATCHEMOTHERAPY OF VARICELLA-ZOSTER VIRU
J SNOECK, R; GERARD, M; SADZOTDELVAUX, C; ANDRE JOURNAL MENINGORADICULONEURITIS DUE TO ACYCLO
J SNOECK, R; SCHOLS, D; SADZOTDELVAUX, C; CLOE JOURNAL FLOW CYTOMETRIC METHOD FOR THE DETEC
J SNOECK, R; ANDREI, G; DECLERCQ, E; GERARD, NEW ENGL A NEW TOPICAL TREATMENT FOR RESISTANT
J Snoeck, R; Andrei, G; De Clercq, E VerhandeliCidofovir in the treatment of HPV-associated lesion
J Srinivasan, S; McGuigan, C; Andrei, G; Snoeck, R; DeNUCLEOSI
C Bicyclic nucleoside inhibitors of varicella-zoster viru
J Stephens, CE; Felder, TM; Sowell, JW; Andrei, G; BalzBIOORGAN Synthesis and antiviral/antitumor evaluation of 2-am
J Stevens, M; Balzarini, J; Tabarrini, O; Andrei, G; SnoeJOURNAL Cell-dependent interference of a series of new 6-am
J Stranska, Ruzena; Gysbrechts, Laurens; Wouters, Jens JOURNAL Comparison of membrane affinity-based method w
J Tatar, Esra; Karakus, Sevgi; Kucukguzel, Sukriye GuniBIOLOGICDesign, Synthesis, and Molecular Docking Studies
J Tatar, Esra; Kucukguzel, Ilkay; Otuk, Gulten; Bilgin, JOURNAL Synthesis, characterization and biological evaluatio
J Tatar, Esra; Kucukguzel, S. Guniz; Karakus, Sevgi; DeMARMARASynthesis and biological evaluation of some new 1
J Temblador, Arturo; Topalis, Dimitrios; van den Oord, JCANCERSOrganotypic Epithelial Raft Cultures as a Three-Dim
J Temblador, Arturo; Topalis, Dimitrios; Andrei, Graciel CANCERSCRISPR/Cas9 Editing of the Polyomavirus Tumor A
J Temblador, Arturo; Topalis, Dimitrios; Andrei, Graciel TUMOUR V Synergistic targeting of the PI3K/mTOR and MAPK
J Thuc Dinh Ngoc; Moons, Nico; Kim, Youngju; De Borgg BIOORGAN Synthesis of triterpenoid triazine derivatives from a
J Tichy, Tomas; Andrei, Graciela; Dracinsky, Martin; Ho BIOORGAN New prodrugs of Adefovir and Cidofovir
J Tichy, Tomas; Andrei, Graciela; Snoeck, Robert; BalzaEUROPEAN Synthesis and antiviral activities of hexadecyloxypr
J Topalis, D.; Lebeau, I.; Krecmerova, M.; Andrei, G.; S ANTIMICRActivities of Different Classes of Acyclic Nucleoside
J Topalis, D.; Andrei, G.; Snoeck, R. ANTIVIRA The large tumor antigen: A "Swiss Army knife" prot
J Topalis, D.; Gillemot, S.; Snoeck, R.; Andrei, G. NUCLEIC Distribution and effects of amino acid changes in d
J Topalis, Dimitri; Gillemot, Sarah; Snoeck, Robert; AndrDRUG RESThymidine kinase and protein kinase in drug-resista
J Topalis, Dimitri; Snoeck, Robert; Andrei, Graciela EBIOMEDITenofovir Activating Kinases May Impact the Outco
J Topalis, Dimitri; Pradere, Ugo; Roy, Vincent; Caillat, JOURNAL Novel Antiviral C5-Substituted Pyrimidine Acyclic N
J Topalis, Dimitri; Nogueira, Tatiane C.; De Schutter, T ONCOTARResistance to the nucleotide analogue cidofovir in H
J Tramontano, Enzo; Tarb Int Soc Antiviral Res ANTIVIRA Meeting report: 32nd International Conference on A
J Trompet, Erika; Topalis, Dimitrios; Gillemot, Sarah; SnANTIVIRA Viral fitness of MHV-68 viruses harboring drug resi
J Trompet, Erika; Temblador, Arturo; Gillemot, Sarah; ToVIRUSES-An MHV-68 Mutator Phenotype Mutant Virus, Conf
J Twite, Nicolas; Andrei, Graciela; Kummert, Caroline; VIROLOGYSequestration of human cytomegalovirus by human
J Van derpoorten, K; Ucar, H; Andrei, G; Snoeck, R; Balz ANTIVIRA Synthesis and antiviral activity of 6-benzoyl-benzox
J Vanderlinden, Evelien; Vrancken, Bram; Van Houdt, Jer ANTIMICRDistinct Effects of T-705 (Favipiravir) and Ribavirin
J Vanheule, Vincent; Vervaeke, Peter; Mortier, Annelee BIOCHEMIBasic chemokine-derived glycosaminoglycan bindin
J VERHEGGEN, I; VANAERSCHOT, A; VANMEERVELT, JOURNAL
L SYNTHESIS, BIOLOGICAL EVALUATION, AND S
J Vermeire, K; Zhang, Y; Princen, K; Hatse, S; Samala, VIROLOGYCADA inhibits human immunodeficiency virus and
J Veron, Jean-Baptiste; Allouchi, Hassan; Enguehard-Gueif BIOORGAN Influence of 6-or 8-substitution on the antiviral activ
J Veron, Jean-Baptiste; Enguehard-Gueiffier, Cecile; Snoe BIOORGAN Influence of 6 or 8-substitution on the antiviral activ
J Verri, A; Focher, F; Duncombe, RJ; Basnak, I; Walker,BIOCHEMIAnti-(herpes simplex virus) activity of 4 '-thio-2 '-deo
J Vigne, Solenne; Duraffour, Sophie; Andrei, Graciela; ANTIMICRInhibition of Vaccinia Virus Replication by Two Sma
J Vigne, Solenne; Germi, Rophaele; Duraffour, Sophie; LANTIVIRA Specific inhibition of orthopoxvirus replication by a
J Vogel, JU; Michaelis, M; Neyts, J; Blaheta, RA; SnoeckANTIVIRA Antiviral and immunomodulatory activity of the met
J Wang, J; Froeyen, M; Hendrix, C; Andrei, G; Snoeck, R JOURNAL The cyclohexene ring system as a furanose mimic:
J Wang, Mengmeng; Srivastava, Puneet; Liu, Chao; Snoec EUROPEAN Synthesis and antiviral evaluation of cyclopentyl nu
J Wauchope, Orrette R.; Johnson, Cameron; Krishnamoort BIOORGAN Synthesis and biological evaluation of a series of th
J Wen, Yi-Ning; Zhang, Zhi-Feng; Liu, Ning-Ning; Andr MEDICINASynthesis and Ativiral Activity of 5-(Benzylthio)-4-ca
J Wen, Yi-ning; Zhang, Zhi-feng; Liu, Ning-ning; Xiang NUCLEOSISynthesis and Bioactivity of Novel Trisubstituted Tr
J Wen, Zhiwei; Suzol, Sazzad H.; Peng, Jufang; Liang, ARCHIV DAntiviral and Cytostatic Evaluation of 5-(1-Halo-2-s
J Wiersum Stranska; Wouters, J.; Bloch, K.; Snoeck, R.;J Extracell Comparison of exoEasy Maxi kit (Qiagen) with size
J Wittine, K.; Benci, K.; Rajic, Z.; Zorc, B.; Kralj, M.; Ma EUROPEAN The novel phosphoramidate derivatives of NSAID 3
J WITVROUW M; SCHOLS D; ANDREI G; SNOECK R; Antiviral ANTIVIRAL ACTIVITY OF LOW-MW DEXTRAN SU
J Witvrouw, M; Daelemans, D; Pannecouque, C; Neyts, A J NTIVIRA Broad-spectrum antiviral activity and mechanism o
J WITVROUW, M; ESTE, JA; MATEU, MQ; REYMEN, D; ANTIVIRA ACTIVITY OF A SULFATED POLYSACCHARIDE
J WITVROUW, M; SCHOLS, D; ANDREI, G; SNOECK, R ANTIVIRA NEW POLYACETAL POLYSULFATE ACTIVE AGA
J Wolfgang, Grushenka H. I.; Shibata, Riri; Wang, Jianyin ANTIMICRGS-9191 Is a Novel Topical Prodrug of the Nucleot
J Wu, JY; Schneller, SW; Seley, KL; Snoeck, R; Andrei, JOURNAL
G Carbocyclic oxetanocins lacking the C-3' methylene
J YAMAMOTO, N; SCHOLS, D; DE CLERCQ, E; DEBYSE MOLECULMECHANISM OF ANTI-HUMAN-IMMUNODEFICIE
J Yuan, Wei-yuan; Chen, Xue; Liu, Ning-ning; Wen, Yi-nMEDICINASynthesis Anti-Varicella-Zoster Virus and Anti-Cyto
J Zdzienicka, Anna; Schols, Dominique; Andrei, Graciel PHOSPHOR PHOSPHONYLATED 8-AZAHYPOXANTINES AS
J Zhang, Xinying; Qu, Yingying; Fan, Xuesen; Bores, C.;NUCLEOSISolvent-Free Synthesis of Pyrimidine Nucleoside-A
J Zheng, Zihua; Groaz, Elisabetta; Snoeck, Robert; De JACS MEDIInfluence of 4 '-Substitution on the Activity of Gemc
J Zimmermann, Sarah C.; Sadler, Joshua M.; Andrei, Grac MEDCHEMCarbocyclic 5 '-nor "reverse" fleximers. Design, syn
 SE BS PY VL IS BP EP AR DI D2
new high-mass phenomena in the2017 dil 10.17182/hepdata.790
top-squark pair production in fina 2017 10.17182/hepdata.793
top-squark pair production in fina 2017 10.17182/hepdata.793
nt of $\chi_{c1}$ and $\chi_{c2}$ pr2014 10.17182/hepdata.642
ent of the production cross section2012 f 10.17182/hepdata.582
ntre External Quality Assessment 2017 96 89 93 10.1016/j.jcv.2017.10
on at the C4 position of pyrimid 2017 15 5 1130 1139 10.1039/c6ob02334g
rinated Sulfonium Derivatives 2021 60 12 8592 8604 DOI 10.1021/ACS.I
al raft cultures as a model for e 2005 49 11 4671 4680 10.1128/AAC.49.11.4
veral clinical Varicella-zoster vi 2005 49 3 1081 1086 10.1128/AAC.49.3.10
compounds against murine and p 1997 41 3 587 593 10.1128/AAC.41.3.58
OF SEVERAL DRUG-RESISTAN1995 39 7 1632 1635 10.1128/AAC.39.7.16
atment of Varicella-Zoster Virus In2013 67 107 168 10.1016/B978-0-12-4
MOR CELL-LINES AS CELL SUBS1994 5 4 263 270 10.1177/0956320294
stance for herpesviruses 2000 24 151 169 10.1385/1-59259-245
hanism of action of cidofovir an 2015 114 21 46 10.1016/j.antiviral.20
s for investigations of virus grow 2010 85 3 431 449 10.1016/j.antiviral.20
rug-resistant varicella-zoster vi 2004 61 3 181 187 10.1016/j.antiviral.20
anciclovir elaidic acid ester again 2000 45 3 157 167 10.1016/S0166-3542(
OACHES FOR THE TREATMENT1993 22 1 45 75 10.1016/0166-3542(9
T OF SELECTED ANTIVIRAL C 1990 14 4-5 287 300 10.1016/0166-3542(9
TIVITY OF SELECTED ANTIVIRA1995 14 4 318 329 10.1007/BF02116525
TIVITY OF VARIOUS COMPOUNDS 1992 11 2 143 151 10.1007/BF01967066
TIVITY OF SELECTED ANTIVIR 1991 10 12 1026 1033 10.1007/BF01984924
als: Grand Challenges and Great 2021 1 66548 66548 DOI 10.3389/FVIRO.
als: grand challenges and great op2021 1
als: Grand challenges and great op 2021 1 666548
er-centered design: a systematic 2017
2018 19 26 26
s simplex virus type 1 against diff 2000 81 639 648 10.1099/0022-1317-8
c composites for aircraft applicatio2006 8 2 726 730
g-Resistant Varicella-Zoster Vi 2012 86 5 2641 2652 10.1128/JVI.06620-11
erpes simplex virus type 1 thyrai 2005 79 9 5863 5869 10.1128/JVI.79.9.586
2010 2403 2428
s by cidofovir in human papillomav 2001 12 9-10 397 408 10.3727/0965040011
cts of acyclic nucleoside phosph 1998 10 10 523 531
idofovir (HPMPC) on the growth 1998 10 10 533 539
Oscillator Design 2009 21 25
2011
olyomavirus BK and acyclovir-resis2007 9 2 126 131 10.1111/j.1399-3062.
2013
stage Doherty architecture based o2011
technology for rotorcraft drive trai 1998
ration Techniques in Biology and Medicine.
ns (What Webster never told you 2000
Y AND CYTOTOXICITY ASSAY 1985 17 4 187 194
cles on Mechanical Behaviour o 2009 46 3 284 287
ment of a Acute Obstructive Left Co 2017 112 6 734 739 10.21614/chirurgia.11
the Management Algorithm in Acu2016 111 1 74 79
luation of cefuroxim loaded submicr 2015 493 1-2 16 29 10.1016/j.ijpharm.201
andon (1852-1922): Bibliography 1993 33 0 481 489
cz (1907-2006). 2006 49 529 534
Middleware: Standards and Perf 2020 10.1109/AICT50176.
s and their Antibacterial Activity - 2021 21 11 1380 1392 10.2174/1389557520

EFRACTORY STATE TO VIRAL-1988 9 4 221 231 10.1016/0166-3542(8

TOR FROM MELIA-AZEDARACH1986 42 7 843 845 10.1007/BF01941548
TIVIRAL COMPOUND FROM MEL 1990 10 5 469 475 10.1089/jir.1990.10.4
-Market Ratio and the Value Prem2020
s: The Ideology of Late Capitalism2020 15 199 219
ytomegalovirus infection in a kidney 2019 168 203 209 10.1016/j.antiviral.20
h International Conference on Ant 2017 145 184 196 10.1016/j.antiviral.20
ulture models for human viral dise2006 71 2-3 96 107 10.1016/j.antiviral.20
tations in drug-resistant herpes si2007 12 5 719 732
DNA Polymerase Mutations Show 2022 10 3 580 10.3390/biomedicine
Microbicide Effective against HIV,2011 10 4 379 389 10.1016/j.chom.2011.
中国药物化学杂志 2016 26 1 18 23 1005-0108(2016)26:1<18:123SD
sociated herpesvirus: the role of lyt
2015 28 6 611 624 10.1097/QCO.000000
drug-resistance: new mutations a2013 26 6 551 560 10.1097/QCO.000000
2008 9 2 132 145
varicella-zoster virus infections 2011 16 3 507 535 10.1517/14728214.20
munodeficiency Virus Drug Tenofovi 2018 217 5 790 801 10.1093/infdis/jix605
volution of Thymidine Kinase and 2013 207 8 1295 1305 10.1093/infdis/jit019
n vaccinia virus is linked to dimin 2006 80 19 9391 9401 10.1128/JVI.00605-06
ectives in the Management of Varic 2021 26 4 1132 10.3390/molecules26
or Epstein-Barr Virus 2019 24 5 997 10.3390/molecules24
se Inhibitors 2009 481 526 10.1007/b135974_22
ainst Poxvirus Infections 2010 2 12 2803 2830 10.3390/v2122803
megalovirus Infection 2009 9 2 201 222
grafii Ukrainy Ella Libanova: Stra 2022
ature on the standard and routine 2018 11 5 1467 1475
Y CRITERIA AND PERFORMANC2008
and generation of curved face wi2002 42 1 1 6 10.1016/S0890-6955(
andard geometry of plastic gear on 2004
sis of Plastic Curved Facewidth S 2005 8 16
lity criteria and performance of cu 2008 14 28 32
cleosides: thieno analogues bearing 2004 14 10 2397 2399 10.1016/j.bmcl.2004.
omated inspection of leading edge2021 11785 117850W
2015
 -deazapurine, 7-deazapurine and 2015
alk 102 288 302 10.1016/j.ejmech.201
Tetrahydropyrimidin-1-yl)-N-(4-P 2015 7 4 142 145 10.32607/20758251-2
y of dual HCMV-VZV inhibitors: Synt 2015 23 21 7035 7044 10.1016/j.bmc.2015.0
g Release Process from Polymeri 2012 653720 10.1155/2012/653720
ance Typing Reveals Compartment 2014 3 2 E24 93 10.1093/jpids/pit045
modulation Society's 13th World 2017 20 e336 783
al activities of some novel carboc 1996 15 7-8 1335 1346 10.1080/0732831960
rdinates of a Hostile Gunfire by 2012 637 640
ives: Structure-activity relationsh 2002 85 9 2961 2974 10.1002/1522-2675(2
oxy)alkoxy]-2,4-diaminopyrimidines:2004 23 8-9 1321 1327 10.1081/NCN-200027
2018 5 453 493
g Candidate with Dual Anti-HIV an2013 9 7 e1003456 10.1371/journal.ppat
2009 44 3480 3480 DOI 10.1016/J.EJMEC
stal structure study, and cytostatic2005 48 3 884 887 10.1021/jm040878r
lubrication in face gears drives 2000
lubrication in face gears drives 2000
nical properties of polyester comp2014 659 22 7 10.4028/www.scientif
graphene oxide/graphite content a2015 110 1569 79
graphene oxide/ graphite content 2015 10 4
nical properties of polyester compo2015 10
TWEEN GRAPHENE OXIDE / GR2015 10 4 1109 1118
CHANICAL PROPERTIES OF PO2015 10 2 521 533
cific heat of polyester composite 2014 36 419 427
properties for polyester/microcell2015 327 329 10.1109/NANO.2015.
Oxide and Graphite on Dry Sliding 2018 55 1 102 110
ehaviour of Polyester Nanocompos2018 69 6 1391 1397
clic Nucleoside Phosphonates with2018 26 1 13
clic nucleoside phosphonates with2018po 26 10.1177/2040206618
ytomegalovirus infection in a pedia2016 132 149 153 10.1016/j.antiviral.20
ed from metal thiolate complexes as 2002 13 3 185 95
olyphenylene sulphide composites2012 d 2 15 20
Synthesis of (E)-2-Methyl-but-2- 2016 1 12 3108 3113 10.1002/slct.2016008
ynthesis and antiviral activity of 2018 146 678 686 10.1016/j.ejmech.201
ctures retain full anti-HCMV potenc2004 15 6 329 332
eoside triazole-based systems as 2 v 023 249 115136 10.1016/j.ejmech.202
ne nucleosides with aryloxyphenyl2001 20 4-7 1063 1066 10.1081/NCN-100002
esent a novel therapeutic option 2021 11 2 27 10.1038/s41408-021-
a Target for Combined Therapy 2015 2 9 1102 1113 10.1016/j.ebiom.2015
cleosides containing a cyclobuty 1998 17 7 1237 1253 10.1080/0732831980
International Conference on Antiv2018 158 88 102 10.1016/j.antiviral.20
ndent pathways underlie the pathog 2018 192 1 104 119 10.1111/cei.13084
te to the pathogenesis of hemoph2017 8 1 8
ute to the Pathogenesis of Hemop2017 8 1102 10.3389/fimmu.2017.
irus Infection in BALB/c Mice Res 2016 196 7 3124 3134 10.4049/jimmunol.15
 and immunopathology in a cyt 2017 14 240 10.1186/s12985-017-
emistry mediated carbanucleosid 2007 26 10-12 1391 1394 10.1080/1525777070
rfering with pipelines: modelling vs1996
Slopes Interfering with Pipelines: 1996 5
nhibitors of varicella-zoster virus: e2002 13 5 263 71
nhibitors of Varicella-Zoster Virus: 2003 22 5-8 935 937 10.1081/NCN-120022
2005 48 1158 1158
alysis Using Deep Learning Model2020 12 3 1030 1030
alysis Using Deep Learning Model2022 12 3 1030 10.3390/app1203103
and thioureidoimidazo[1,2-a]pyridin2001 49 12 1631 1635 10.1248/cpb.49.1631
NTIVIRAL ACTIVITY OF 5'-DE 1993 36 23 3727 3730 10.1021/jm00075a03
uoro-5-phosphono-pent-2-en-1-yl N 2017 7 32282 32287
Fasc. Ix. Metal. Mater. Sci 2015 38 41 41
erization of Graphite and Graphene / Vinyl-E 4
erization of Graphite and Graphene 2016 53
erization of Graphite and Graphen2016 11 21 21
ation of antiviral, antitubercular 2010 14 1 13 20 10.12991/201014460
y of Fabric Based Filled Epoxy 2009 46 2 211 214
S OF STRATIFIED COMPOSITES2010 679 682
D THERMAL EXPANSION OF P 2013 8 4 1611 1619
1991 35 679 684 DOI 10.1007/s00109-
sm of Action of HDVD, a Novel Py2013 87 87
sm of Action of HDVD, a Novel Py2013 87 7 3839 3851 10.1128/JVI.03338-12
and Mechanisms of Resistance o 2014 58 12 7312 7323 10.1128/AAC.03957-
vities of Two Novel 4 '-Thiothym 2014 58 8 4328 4340 10.1128/AAC.02825-
Acyclic Nucleoside Phosphonates2013 87 22 12422 12432 10.1128/JVI.02231-13
rapy: An Update on Inhibitors of Vir 2014 6 11 4731 4759 10.3390/v6114731
placement of electric vehicle charg2017
Analysis and Wear Behavior of C 2019 70 3592 3596
rmal Behavior of Carbon Nanotube 2019 56 4 735 743
Analysis and Wear Behavior of C 2019 70 10 3592 3596
ING LEVELS ON GROWTH PER2019 62 2 341 347
arabinouridine and 2'-deoxyuridine2007 50 12 2851 2857 10.1021/jm0701472
f Nuclear Export (SINE) Comp 2015 126 23
ucleoside phosphonates against 2005 49 12 4843 4852 10.1128/AAC.49.12.4
the anti-orf virus activity of a 2007 75 1 52 57 10.1016/j.antiviral.20
antiviral assay for the evaluation 2008 151 1 66 73 10.1016/j.jviromet.20
Y OF A SULFATED POLYSAC 1994 47 12 2187 2192 10.1016/0006-2952(9
d cell-mediated inhibition of huma 2004 67 2 325 336 10.1016/j.bcp.2003.0
ert-butyldimethylsilyl)-beta-D-ribof2005 48 4 1158 1168 10.1021/jm040868q
mma-sultone to Unusual Bicyclic Pyr 2011 6 4 686 697 10.1002/cmdc.20100
-Sultone Derivatives: Discovery of2009a 52 9 3121 3121 10.1021/jm900444d
-Sultone Derivatives: Discovery of2009 52 6 1582 1591 10.1021/jm8014662
SAO derivatives as potent and sele2008 51 18 5823 5832 10.1021/jm800050t
e human cytomegalovirus inhibitors 2007 26 6-7 625 628 10.1080/1525777070
 a new generation of acyclic nu 2005 24 5-7 331 341 10.1081/NCN-200059
uanosine analogues as anti-herpe2001 20 4-7 271 285 10.1081/NCN-100002
f acyclic nucleoside phosphonate 1999 18 4-5 759 771 10.1080/1525777990
s based on the different respon 2013 6 18 10.1186/1755-8794-6
mproves the pathology caused by 2013 329 2 137 145 10.1016/j.canlet.2012
city and pathogenicity of cervical ca2013 12 158 10.1186/1476-4598-1
IES OF 5-ETHYNYL-1-BETA 1991 35 4 679 684 10.1128/AAC.35.4.67
thymidine kinase gene and anti 1997 4 10 1107 1114 10.1038/sj.gt.330050
ucleoside and nucleotide analogues locked in North conformation
ucleoside and nucleotide analogue 2015 23 1 184 191 10.1016/j.bmc.2014.1
tion of polymer composite using b2010
nd Water Lubrication. II. Surface C2008 45 4 332 338
nd water lubrication - I. Tribogical c2007 44 1 66 71
phosphoramidate ProTides of the 22010 ' 21 1 15 31 10.3851/IMP1661
d biological evaluation of novel a 2008 78 2 A55 A56 10.1016/j.antiviral.20
Acyclovir Derivatives as Potentia 2017 60 18 7876 7896 10.1021/acs.jmedche
of the Zonulin Inhibitor Larazotid 2021 22
e zonulin inhibitor AT1001 deriva 2022 244 114857 10.1016/j.ejmech.202
of the Zonulin Inhibitor Larazotid 2021 22 17 9427 10.3390/ijms2217942
al acting SARS-CoV-2 proteases in 2021 226 113863 10.1016/j.ejmech.202
wind energy potential of the we 2021 7 112 118 10.1016/j.egyr.2021.0
wer Shape Effect on the Stress-S 2022 7 1 11 10.3390/inventions70
on Wind Energy Potential in Six R2021 6 3 44 10.3390/inventions60
IV Dependent Water-Soluble Prodr 2011 54 6 1927 1942 10.1021/jm101624e
ffect of Fe3O4 particles on the i 2003 34 4 349 353 10.1002/mawe.20039
ferrite particles and oxygen molec2004 49 9-10 795 806
ARBON NANOTUBES COATED WIT 2010 5 4 1009 1014
NTIVIRAL ACTIVITY OF 3 PYRA 1994 48 6 498 505 10.3891/acta.chem.s
noid triazine derivatives from allob2014 22 3392 3300
a as a postoperative risk factor in t2021 6 2 136 140 DOI 10.25083/2559.55
t-dependent risk factors on morbidi2021 8 2 14 10.22543/7674.82.P2
Fasc. IX. Metall. Mat. Sci 2013 36 49 53
apons against poxvirus 2008 12 5 323 338 10.1684/vir.2011.121
Nucleoside Analogue Inhibitor of Or2014 58 1 27 37 10.1128/AAC.01601-
classes of acyclic nucleoside phos2007 51 12 4410 4419 10.1128/AAC.00838-
2011 92 2 167 186 10.1016/j.antiviral.20
thopoxvirus compound ST-246 ag2007 12 8 1205 1216
nvelope protein inhibitor for the tr 2010 13 3 181 191
viral to inhibit the viral F13L phos 2015 70 5 1367 1380 10.1093/jac/dku545
Resistance to Viral DNA Polymeras 2012 86 13 7310 7325 10.1128/JVI.00355-12
ox: Study of the Virulence of Clinica2013 8 2 e55808 10.1371/journal.pone
Virus Pathogenesis in Athymic Nu 2011 6 6 e21561 10.1371/journal.pone
the F13L protein by ST-246 affect2008 13 8 977 990
e derivatives of N-alkyl, cycloalkyl 2008
o 43 6 1180 1187 10.1016/j.ejmech.200
uro[2,3-d]pyrimidin-2-one-1,3,4-oxa2021 354 10 e2100146 10.1002/ardp.202100
hemical characterization, biologi 2020 39 8 1088 1107 10.1080/15257770.20
al activity of new pyrazole and thi2009 44 9 3746 3753 10.1016/j.ejmech.200
NTIVIRAL ACTIVITY OF 3-SUBST1994 4 16 1937 1940 10.1016/S0960-894X(
al activity of 3-substituted imidaz 1994 4 19 19
t synthesis of pyrano[3,2-c]pyrido 2010 20 3 809 813 10.1016/j.bmcl.2009.
2014 14 P79 P79 10.1186/1471-2334-1
e labyrinthopeptin A1 demonstrate2013
a novel lantibiotic peptide, is a d 2013 2 53 4
opeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications
de Labyrinthopeptin A1 Demonstrat 2013 8 5 e64010 10.1371/journal.pone
e labyrinthopeptin Al demonstrates 2013 8 5 e64010
al and cytostatic activities of ca 1999 332 10 348 352 10.1002/(SICI)1521-
ine Deaminase-like (ADAL) Protei2013 33 5 1899 1912
al activities of 3-aralkylthiomethy 2003 14 4 177 182
DNA virus protein disarms inverteb2014 3 e02910 10.7554/eLife.02910
al Drug Resistance of Vaccinia Vir2008 82 24 12520 12534 10.1128/JVI.01528-08
ded Ribonucleotide Reductase Subu 2010 6 7 e1000984 10.1371/journal.ppat
c and anti-HIV Evaluations of th 2008 16 10
and anti-HIV evaluations of the 2008 16 10 5624 5634 10.1016/j.bmc.2008.0
al and cytostatic evaluations of th2007 50 17 4105 4112 10.1021/jm070324z
2018 173 976 983
CMV activity of 1-acyl-beta-lacta 2004 14 9 2253 2256 10.1016/j.bmcl.2004.
tam human cytomegalovirus protease 2005 48 7 2612 2621 10.1021/jm0492812
s of a new series of hybrids of funct 2023 209 105518 10.1016/j.antiviral.2
nd the Biological Evaluation of a 2017 350 9 e1700166 10.1002/ardp.201700
ntiviral and cytostatic activity of 2014 22 14 3629 3641 10.1016/j.bmc.2014.0
3-Aryl-4-(diethoxyphosphoryl)azet2021 22 15 8032 10.3390/ijms2215803
ological Activity of Phosphonylat 2016 21 11 1420 10.3390/molecules21
clic Guanosine Analogues with the2015 20 10 18789 18807 10.3390/molecules20
hosphonates containing the amide2019 150 4 733 745 10.1007/s00706-019-
hosphonates containing the amid 2016 147 12 2163 2177 10.1007/s00706-016-
GS OF ACYCLOVIR AND GANCIC 1994 37 19 3187 3190 10.1021/jm00045a02
ound Lignosulfonic Acid (LA) Exhibi 2015 10 7 e0131219 10.1371/journal.pone
ralistskii povorot 1997 2
2016 21 1420 1420
2015 20 18789 18807
2016 147 2163 2163
2016 147 2163 2163 DOI 10.1007/S00706-
ates of N3-Substituted 6-Bromoqui 2018 23 8 1889 10.3390/molecules23
[1,2-a]pyridines as antiviral agent 1998 41 25 5108 5112 10.1021/jm981051y
C-nucleosides in the imidazo[1,2-a] 1996 39 14 2856 2859 10.1021/jm9507901
maging" of human gliomas using 2021 32 102882 10.1016/j.nicl.2021.1
spectrum antiviral evaluation of 2013 67 398 408 10.1016/j.ejmech.201
tituted 2 '-deoxy-4 '-thiocytidines a2019 75 33 4542 4555 10.1016/j.tet.2019.06
al evaluation of phosphoramidate 2001 12 5 293 300 10.1177/0956320201
 d antiviral evaluation of novel ac 2020 39 4 542 591 10.1080/15257770.20
al activity of acyclic nucleotide 1996 61 10 1525 1537 10.1135/cccc1996152
al activity of 2,4-diamino-5-cy 2004 12 12 3197 3202 10.1016/j.bmc.2004.0
amino-6-[2-(phosphonomethoxy)etho 2003 46 23 5064 5073 10.1021/jm030932o
hosphonates with a branched 2-(2-p 2011 19 15 4445 4453 10.1016/j.bmc.2011.0
hoxy)alkoxy]pyrimidines with antivir 2002 45 9 1918 1929 10.1021/jm011095y
tivity relationship in the series 1999 42 12 2064 2086 10.1021/jm9811256
nalogs derived from 8-azapurines: 1996S 39 20 4073 4088 10.1021/jm960314q
ogs of PMEG and PMEDAP: Synthes 2006 14 23 8057 8065 10.1016/j.bmc.2006.0
ynyl-- D-ribofuranose purine nucl 2018 157 157
core of 3 '-C-ethynyladenosine (E2016 26 8 1970 1972 10.1016/j.bmcl.2016.
ethyny1-beta-D-ribofuranose purin2018 157 248 267 10.1016/j.ejmech.201
on tribological behavior between m 2017 174 184
on tribological behavior between m 2017 012015
on tribological behavior between m 2017 174 UNSP 01210.1088/1757-899X/1
ehavior of Moglice Polymer Composi 2015 808 137 42 10.4028/www.scientif
ion of the Worn Surfaces under 2014 657 437 + 10.4028/www.scientif
combined with facilitation technique 2017 8 4 241 244 10.12680/balneo.201
d techniques: Scottish showers, ho2017 8 4 245 247 10.12680/balneo.201
mbines High Power and Efficienc 2017 63 52 56
ical evaluation of acyclic 3-[(2-hy 2005 48 14 4690 4696 10.1021/jm050291s
ical evaluation of acyclic nucleot 2010 88 7 628 638 10.1139/V10-054
ical evaluation of 5-(alkyn-1-yl)-1-2006 84 4 580 586 10.1139/V06-041
midine nucleosides with 5-alkynyl 2021 209 112884 10.1016/j.ejmech.202
/1,2,3-triazole hybrid molecules: Sy 2018 155 772 781 10.1016/j.ejmech.201
nd anticancer activity of some 2009 44 9 3591 3595 10.1016/j.ejmech.200
rimidin- 2(1H)-one Hybrids: Synthes 2022 17 e202200031
ovir (core)-dexpanthenol (sheath) n 2022 611 10.1016/j.ijpharm.20
-Substituted Uracils: Potential Age2022 27 9 2866 10.3390/molecules27
tory Brain Potentials during Car D2012 3829 3832 10.1109/EMBC.2012.
2019 8 5610 5623
ations of "1,4-Triazolyl Combret 2019 2019 33 5610 5623 10.1002/ejoc.201900
cytostatic properties of isoxazo 2015 23 13 3135 3146 10.1016/j.bmc.2015.0
nd Biological Evaluation of Novel 2020 16 3 368 384 10.2174/1573406415
carbonyl)pyridine and 1-acetyladama 2002 12 5 723 727 PII S0960X10.1016/S0960-894X(
al activity evaluation of some n 1996 39 17 3307 3318 10.1021/jm950891z
ia Responsibility in Medicine and 2022 38 02 131 134 10.1055/s-0041-1741
trum of phenoxazine nucleoside d2019 163 117 124 10.1016/j.antiviral.20
side derivatives with a multiple ac 2021 220 113467 10.1016/j.ejmech.202
pyrimidine acyclic nucleoside phos 2017 25 17 4637 4648 10.1016/j.bmc.2017.0
as lipophilic prodrugs of cidofovi 2014 22 10 2896 2906 10.1016/j.bmc.2014.0
rodrugs of 9-(S)-[3-Hydroxy-2-( 2010 53 19 6825 6837 10.1021/jm901828c
clic 1-(S)-[3-hydroxy-2-(phosphono2007 50 23 5765 5772 10.1021/jm0707166
azine analogues of 1-(S)-[3-h 2007 50 5 1069 1077 PII S0022-10.1021/jm061281+
E/F-3 High Frequency Oscillator 2018 607 611 10.1109/TCSET.2018
o nucleoside phosphonate analog 2008 64 16 3517 3526 10.1016/j.tet.2008.01
acetyl-1,3,4-oxadiazolines combined 2022 10.1007/s11030-022-
oxic activity of N-ind-alkoxy deriv 2002 55 8 768 773 10.7164/antibiotics.5
gical Properties of C-2 Triazolylino2012 77 14 5870 5883 10.1021/jo300628y
kyl esters of cidofovir (CDV), c 2012 50
three classes of acyclic nucle 2007 51 6 2268 2273 10.1128/AAC.01422-
kyl esters of cidofovir (CDV), c 2006 50 7 2525 2529 10.1128/AAC.01489-
s ORF9p Binding to Cellular Adapto 2018 92 15 e00295-1810.1128/JVI.00295-18
of HIV and other viruses. 7. Poly 1998 41 25 4927 4932 10.1021/jm970661f
of human immunodeficiency virus 1997 40 3 342 349 10.1021/jm960493b
of human immunodeficiency virus 1997 40 3 350 356 10.1021/jm960348y
of human immunodeficiency virus 1996 39 8 1626 1634 10.1021/jm950358j
TORS OF HUMAN-IMMUNODEFIC 1995 38 13 2433 2440 10.1021/jm00013a01
al activity of imidazo[1,2-a]pyridin1999 34 3 271 274 10.1016/S0223-5234(
plasmonic nanomatryoshkas: Shrin 2015 15 6419 6428
emangioma formation in rats by t 1998 58 12 2562 2567
en caravana: sobrevivir o ser vict 2019 7 54 63
on health impact of the chemicals 2018 10 1 15
O-2-Alkylated Pyrimidine Acyclic 2020 11 7 1410 1415 10.1021/acsmedcheml
Cyclic 9-(S)-[3-Hydroxy-2(phosph2018 9 4 381 385 10.1021/acsmedcheml
ral Spectrum of 3-Fluoro-2-(pho 2017 60 14 6220 6238 10.1021/acs.jmedche
nhibitors of Varicella-Zoster virus: 2005 15 16 3791 3796 10.1016/j.bmcl.2005.
nhibitors of Varicella-Zoster Virus: 2003 22 5-8 931 933 10.1081/NCN-120022
nhibitors of varicelia-zoster virus 2004 15 6 333 341
al activities of 4-substituted 1,2,3 2019 184 111739 10.1016/j.ejmech.201
Speed and Average Pressure in 2009 VIII XV 64 64
ydrazinecarbodithioates: synthesis2013 67 6 650 656 10.2478/s11696-013-
erpetic Activity of Phosphoramida2013 8 6 985 993 10.1002/cmdc.20130
binidze mindia, gogoladze george,2016 v 44 D1104 D1112
ylphthalimides: Synthesis, antiviral2020 353 6 e2000024 10.1002/ardp.202000
Efficiency of the Floating Solar 2023 11 1 203 10.3390/jmse110102
uro [2,3-d]pyrimidin-2-one-1,3,4-ox2021 354 2100146
e Tool for Polyoma BK Virus VP 2020 12 8 837 10.3390/v12080837
ioxides: Synthesis and antiviral act1999 7 8 1617 1623 10.1016/S0968-0896(
an cytomegalovirus inhibitors: Synth 2000 43 17 3267 3273 10.1021/jm000118q
ts for human cytomegalovirus infec 1999 42 7 1145 1150 10.1021/jm980327z
IV-1 and Anti-RCMV activity of 1-s2006 54 3 325 333 10.1248/cpb.54.325
al activity of 6-chloropurine arabin1996 44 12 2331 2334
NTIVIRAL ACTIVITY OF CARBO 1993 41 3 516 521
al activity of 1,3-disubstituted u 2003 14 5 271 279
(3,5-dimethylbenzyl)uracil deri 2007 26 10-12 1553 1558 10.1080/1525777070
terodimers of a New Type: Synthes 2020 25 15 3350 10.3390/molecules25
[1,2-a] pyridine derivatives as anti2001 51 4 304 309
uent on the activity of imidazo[1 2002 10 4 941 946 PII S0968-10.1016/S0968-0896(
as novel potent and selective anti 2001 12 2 77 89 10.1177/0956320201
 pyrimidines with dual anti-VZV a 2003 13 24 4511 4513 10.1016/j.bmcl.2003.
uro pyrimidine deoxynucleoside a2000 25 11 1151 1161 10.1358/dof.2000.025
amily of inhibitors of human cyto 2004 47 7 1847 1851 10.1021/jm030857h
lective inhibition of varicella-zost 2000 43 26 4993 4997 10.1021/jm000210m
inhibition of varicella-zoster vir 1999 42 22 4479 4484 10.1021/jm990346o
d bicyclic furo nucleosides as ex 2001 20 4-7 287 296 10.1081/NCN-100002
2010 43 4993 4993
2 '-deoxyuridine))prop-2-ynyl)octa2014 22 9 2816 2824 10.1016/j.bmc.2014.0
icyclic nucleoside analogues reta 2009 17 8 3025 3027 10.1016/j.bmc.2009.0
ogues of the highly potent anti-va 2009 19 22 6264 6267 10.1016/j.bmcl.2009.
ypass with new acyclovir phospho 2008 18 15 4364 4367 10.1016/j.bmcl.2008.
ent of bicyclic nucleoside analogues 2007 60 6 1316 1330 10.1093/jac/dkm376
al activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives
ION OF 9H-PYRIMIDO[4,5-B][1, 1994 50 47 13511 13522 10.1016/S0040-4020(
r-tumor interactions in a double 2018 9 31 21978 22000 10.18632/oncotarget.
ainst human papillomavirus pos 2016 7 30 47302 47318 10.18632/oncotarget.
al activity of the carbocyclic anal 2007 50 26 6485 6492 10.1021/jm070357e
g for a new type of 6(R)under-bar2018 126 14 33 10.1016/j.mechmacht
the absorbed power estimation 2020 234 1 185 197 14644193110.1177/1464419319
nome Comparison Shows High Geneti 2022 14 7 1533 10.3390/v14071533
SV activity of tricyclic penciclovi 2019 27 6 1023 1033 10.1016/j.bmc.2019.0
-(1-substituted-1,2,3-triazol-4 or 5-2011 46 2 778 786 10.1016/j.ejmech.201
1981 23 407 413
e of herpes simplex virus type 1 s1996 7 5 270 275
LYESTER COMPOSITES WITH F2014 9 2 653 665
dol-based derivative as potent and selective varicella zoster virus (VZV) inhibitor
dol-based derivative as potent and2016 124 773 781 10.1016/j.ejmech.201
ties of several classes of nucleo 2005 49 3 1010 1016 10.1128/AAC.49.3.10
PMEA (adefovir) and related acyclic 1997 8 1 1 23
ctivity and structure-activity rel 2009 82 1 89 94 10.1016/j.antiviral.20
f new arylsulfone derivatives wit 2006 72 1 60 67 10.1016/j.antiviral.20
sm of the new antiviral compou 2008 76 8 997 1005 10.1016/j.bcp.2008.0
2004 14 2253 2256
am Human Cytomegalovirus Protease 2005 48 2612 2621
activity of H2G [(R)-9-[4-hydrox 1998 42 12 3285 3289 10.1128/AAC.42.12.3
uppressive agent mycophenolate mofetil1998 42 2 216 222
ESVIRUS ACTIVITY OF N-7-SU 1995 39 1 56 60 10.1128/AAC.39.1.56
TED ACYCLIC NUCLEOSIDE ANA 1994 38 12 2710 2716 10.1128/AAC.38.12.2
TIVIRAL ACTIVITY OF DERIVAT 1995 50 6 743 751 10.1016/0006-2952(9
sm of the N7-substituted acyclic 1998 53 1 157 165 10.1124/mol.53.1.157
n challenges in Pliocene gas-bear 2018 66 10.1051/e3sconf/201
analysis as a tool for enhanced wel 2016 60 49 61
cal resistivity tomography for imag2021 69 2 613 630 10.1007/s11600-020-
cal Soundings to characterize se 2019 67 6 1845 1863 10.1007/s11600-019-
CMV activity of 1-[omega-(phenoxy 2013 21 14 4151 4157 10.1016/j.bmc.2013.0
d uracils as nonnucleoside inhibito2013 21 5 1150 1158 10.1016/j.bmc.2012.1
hances killing of UVB-damaged ke2012 52 6 1111 1120 10.1016/j.freeradbio
logues .7. Synthesis and antiviral ac1996 39 19 3847 3852 10.1021/jm960145+
Amino acid derivatives of hydroxyure 2005 48 2 475 482 10.1021/jm040869i
ZV activity of 6-heteroaryl derivati2009 44 8 3313 3317 10.1016/j.ejmech.200
- AND N-3-(2-PHOSPHONOMET2011 83 4 797 813 10.3987/COM-11-121
nd Antiviral Activity of Novel Ri 2016 349 1 30 41 10.1002/ardp.201500
2018 10 6 197 10.3390/cancers1006
idazopyridine Nucleoside Derivat 2020 25 19 4531 10.3390/molecules25
ral Properties of 1-Substituted 3-[ 2020 12 3 134 139 10.32607/actanaturae
vatives containing (omega-p-bromoph 2020 30 5 602 603 10.1016/j.mencom.20
oumarin conjugates as potential inh 2019 29 6 638 639 10.1016/j.mencom.20
2004 21 6 30 37
s and Antiviral Activity Evaluation 2014 12 1 104 111
NTIVIRAL PROPERTIES OF (+/ 1992 35 18 3372 3377 10.1021/jm00096a01
studies on azetidine-containing di 2011 19 3 1155 1161 10.1016/j.bmc.2010.1
prodrugs of C5-substituted pyrimidin 2017 143 262 268 10.1016/j.antiviral.20
and biological evaluation of alke 2018 26 12 3596 3609 10.1016/j.bmc.2018.0
OLOGICAL ACTIVITY OF NOVE2017 74 4 1091 1100
ella-zoster virus and anti-cytomeg 2017 126 84 100 10.1016/j.ejmech.201
and gamma-Lactam Analogues of2019 24 22 4014 10.3390/molecules24
onjugates of QuinazolinonesSynthesi 2016 21 7 959 10.3390/molecules21
analogues of homonucleosides a 2016 72 50 8294 8308 10.1016/j.tet.2016.10
cleoside derivatives: Synthesis and 2018
a 144 93 103 10.1016/j.ejmech.201
xolanes in the Synthesis of alpha 2019 38 2 119 156 10.1080/15257770.20
ted acyclic nucleoside phosphona2019 75 39 130529 10.1016/j.tet.2019.13
al evaluation of bis(POM) prodrugs 2012 57 126 133 10.1016/j.ejmech.201
ic evaluation of the novel 6-acycl 2005 16 5 327 338
dural hematoma: case report 2008 22 5
d biological evaluation of 2 '-deox2011 19 14 4338 4345 10.1016/j.bmc.2011.0
ar meshing quality based on transm 2018 444 052011 10.1088/1757-899X/4
d preliminary antiviral screening 2010 19 9 1025 1035 10.1007/s00044-009-
ntiviral activity of new aurintricarb 1996 7 3 142 152 10.1177/0956320296
compounds. Part 131. Synthesis an 2006 49 1 391 398 10.1021/jm050867d
al evaluation of 6-(Alkyl-heteroar 2007 50 16 3897 3905 10.1021/jm070210n
cytotoxic and cytostatic evaluatio 2016 147 6 1081 1090 10.1007/s00706-016-
NTIVIRAL ACTIVITIES OF 8-AL 1994 37 9 1307 1311 10.1021/jm00035a01
ical evaluation of 1,2-disubstitut 1999 18 4-5 733 734 10.1080/1525777990
al evaluation of C5-substituted-(1 2012 53 220 228 10.1016/j.ejmech.201
pic cultures applied to the ex vivo st2005 29 245 247 10.1007/s11259-005-
in herpes simplex viruses: Preval 2022 206 115322 10.1016/j.bcp.2022.1
ral replication fitness of HSV-1 c 2022 77 11 3153 3162 10.1093/jac/dkac297
erpes simplex encephalitis in a pa2014 59 1 67 70 10.1016/j.jcv.2013.10
are potent and selective inhibitors1990 1 4 233 240 10.1177/0956320290
fluoro-3 '-deoxyribonucleosides an2014 22 21 6174 6182 10.1016/j.bmc.2014.0
 logues .6. Synthesis and potent ant 1996 39 12 2392 2399 10.1021/jm950853f
ANALOGS .1. SYNTHESIS OF 61992 35 2 324 331 10.1021/jm00080a01
OMERIC PREFERENCE FOR 5' 1994 37 4 551 554 10.1021/jm00030a01
macological characteristics of the bi2003 22 5-8 995 997 10.1081/NCN-120022
egies fail to prevent the growth o 2003 90 1 91 95 10.1016/S0090-8258(
apoptotic effects of iron chelato 2002 85 1 95 102 10.1006/gyno.2001.6
ances aids-associated Kaposi's s2002 100 2 140 143 10.1002/ijc.10475
o-factor in the pathogenesis of K 1998 78 6 720 726 10.1002/(SICI)1097-
the growth and induce the apopto2000 115 5 893 900 10.1046/j.1523-1747.
s of acyclic nucleoside phosphonat2002 46 11 3356 3361 10.1128/AAC.46.11.3
TENTIATES THE ACTIVITY OF 1994 5 5 312 321 10.1177/0956320294
yl-5,6,7,8-tetrahydroindolizine- 2002 55 3 413 424 PII S0166-10.1016/S0166-3542(
TY OF S-ADENOSYLHOMOCYS1993 21 3 197 216 10.1016/0166-3542(9
Y OF ANTICYTOMEGALOVIRU 1991 16 1 1 9 10.1016/0166-3542(9
ATMENT OF PROGRESSIVE MUC 1994 18 4 570 578 10.1093/clinids/18.4.
gical approaches to the therapy of 1999
va 57 2 187 206 10.2165/00003495-1
e and sensitivity to antiviral com 1996 15 7 574 579 10.1007/BF01709366
ERENT ANTIVIRAL DRUG-COM 1992 11 12 1144 1155 10.1007/BF01961133
OF VARICELLA-ZOSTER VIRUS-1994 4 3 211 226 10.1016/0924-8579(9
ONEURITIS DUE TO ACYCLOVIR 1994 42 4 338 347 10.1002/jmv.1890420
C METHOD FOR THE DETECTION 1992 38 2 243 254 10.1016/0166-0934(9
REATMENT FOR RESISTANT HE1993 329 13 968 969 10.1056/NEJM19930
ment of HPV-associated lesions. 2001 63 2 93
nhibitors of varicella-zoster virus 2001 20 4-7 763 766 10.1081/NCN-100002
al/antitumor evaluation of 2-ami 2001 9 5 1123 1132 10.1016/S0968-0896(
ference of a series of new 6-amino2005 56 5 847 855 10.1093/jac/dki328
brane affinity-based method with si2018 16 1 10.1186/s12967-017-
nd Molecular Docking Studies of a2016 39 4 502 515 10.1248/bpb.b15-006
ization and biological evaluation 2021 25 4 507 518 10.29228/jrp.41
ical evaluation of some new 1,3,4-t2015 19 2 88 102
al Raft Cultures as a Three-Dimen2022 14 4 1091 10.3390/cancers1404
g of the Polyomavirus Tumor Antige 2019 11 9 1260 10.3390/cancers1109
of the PI3K/mTOR and MAPK/ERK 2022 14 200244 10.1016/j.tvr.2022.20
noid triazine derivatives from allob2014 22 13 3292 3300 10.1016/j.bmc.2014.0
efovir and Cidofovir 2011 19 11 3527 3539 10.1016/j.bmc.2011.0
al activities of hexadecyloxypro 2012 55 307 314 10.1016/j.ejmech.201
Classes of Acyclic Nucleoside 2011 55 5 1961 1967 10.1128/AAC.01809-
gen: A "Swiss Army knife" protein 2 p013 97 2 122 136 10.1016/j.antiviral.20
cts of amino acid changes in dru 2016 44 20 9530 9554 10.1093/nar/gkw875
d protein kinase in drug-resistant 2018 37 1 16 10.1016/j.drup.2018.
Kinases May Impact the Outcome2015 2 9 1018 1019 10.1016/j.ebiom.2015
ubstituted Pyrimidine Acyclic N 2011 54 1 222 232 10.1021/jm1011462
cleotide analogue cidofovir in HPV2016 7 9 10386 10401 10.18632/oncotarget.
International Conference on Anti 2019 169 104550 10.1016/j.antiviral.2
68 viruses harboring drug resista 2020 182 104901 10.1016/j.antiviral.2
 Phenotype Mutant Virus, Confirme2021 13 6 985 10.3390/v13060985
man cytomegalovirus by human ren 2014 460 55 65 10.1016/j.virol.2014.
al activity of 6-benzoyl-benzoxaz 1999 10 2 87 97 10.1177/0956320299
705 (Favipiravir) and Ribavirin o 2016 60 11 6679 6691 10.1128/AAC.01156-
rived glycosaminoglycan binding pept 2016 100 73 85 10.1016/j.bcp.2015.1
OGICAL EVALUATION, AND STR 1995 38 5 826 835 10.1021/jm00005a01
n immunodeficiency virus and human 2002 302 2 342 353 10.1006/viro.2002.16
ubstitution on the antiviral activi 2008 16 21 9536 9545 10.1016/j.bmc.2008.0
ubstitution on the antiviral activ 2007 15 22 7209 7219 10.1016/j.bmc.2007.0
virus) activity of 4 '-thio-2 '-deox 2000 351 319 326 10.1042/0264-6021:3
Virus Replication by Two Small 2009 53 6 2579 2588 10.1128/AAC.01626-
orthopoxvirus replication by a s 2008 13 3 357 368
omodulatory activity of the metal ch2002 55 1 179 188 PII S0166-10.1016/S0166-3542(
g system as a furanose mimic: Synt 2000 43 4 736 745 10.1021/jm991171l
al evaluation of cyclopentyl nuc 2018 150 616 625 10.1016/j.ejmech.201
ical evaluation of a series of thie 2012 20 9 3009 3015 10.1016/j.bmc.2012.0
al Activity of 5-(Benzylthio)-4-ca 2017 13 5 453 464 10.2174/1573406413
tivity of Novel Trisubstituted Tria 2016 35 3 147 160 10.1080/15257770.20
tic Evaluation of 5-(1-Halo-2-sulfo2017 350 3-4 e1700023 10.1002/ardp.201700
asy Maxi kit (Qiagen) with size-exc2016 5 31552 31552 DOI 10.3402/JEV.V5.
amidate derivatives of NSAID 3-hydro 2009 44 1 143 151 10.1016/j.ejmech.200
Y OF LOW-MW DEXTRAN SUL 1991 2 3 171 180
viral activity and mechanism of anti1998 9 5 403 411 10.1177/0956320298
LFATED POLYSACCHARIDE E 1994 5 5 297 303 10.1177/0956320294
POLYSULFATE ACTIVE AGAIN 1992 3 6 351 360 10.1177/0956320292
Topical Prodrug of the Nucleotide 2009 53 7 2777 2784 10.1128/AAC.00103-
cins lacking the C-3' methylene 1997 40 9 1401 1406 10.1021/jm960770e
NTI-HUMAN-IMMUNODEFICIENCY 1992 42 6 1109 1117
ella-Zoster Virus and Anti-Cytomega 2019 15 7 801 812 10.2174/1573406414
D 8-AZAHYPOXANTINES AS ACY2015 190 12 2207 2221 10.1080/10426507.20
sis of Pyrimidine Nucleoside-Amino 2010 29 8 616 627 PII 92456810.1080/15257770.20
titution on the Activity of Gemc 2021 12 1 88 92 10.1021/acsmedcheml
everse" fleximers. Design, synthes2011 2 7 650 654 10.1039/C1MD00094
TC
1
2
1
1
1
9
15
1
35
56
193
23
25
5
6
32
27
30
12
86
81
68
47
65
4
1
2
1
1
53
17
37
39
2
61
73
40
2
1
20
1
1
1
1
 1
16
11
1
5
23
1
1
1
17
1
12
23
21
1
1
5
8
34
38
6
92
2
11
62
48
24
11
34
67
33
50
22
89
65
1
2
1
25
1
2
1
14
1
5
 4
13
3
9
20
9
1
11
1
32
27
1
14
1
19
1
1
2
1
1
1
1
35
10
2
6
2
1
2
3
17
3
7
9
2
5
7
3
22
12
7
4
2
46
34
 8
19
1
1
3
2
7
1
8
11
20
3
1
1
1
1
30
13
2
12
4
1
16
17
12
15
39
1
1
1
1
2
42
1
35
30
22
68
62
30
22
1
32
17
7
 58
54
46
16
8
8
105
42
1
18
1
3
12
6
2
8
1
4
9
15
6
4
5
16
11
2
12
28
1
4
2
1
2
11
44
38
64
24
43
15
29
15
19
44
17
 12
283
84
1
125
2
1
1
1
98
1
11
6
6
11
32
59
1
64
45
1
52
43
1
8
28
1
6
5
1
2
46
44
1
2
3
1
1
10
208
173
5
20
6
19
 7
28
59
96
11
128
175
74
15
1
5
14
1
1
3
2
4
9
5
1
69
14
18
5
43
57
1
9
2
27
2
5
25
7
58
134
1
14
8
25
12
24
48
77
2
 36
3
14
25
1
25
35
12
45
16
21
19
21
231
1
32
1
1
7
10
22
17
3
5
21
1
8
14
1
7
2
1
5
15
25
18
25
13
40
16
9
4
31
54
27
 12
36
52
172
178
3
1
25
7
5
17
61
1
4
2
10
20
6
2
1
4
57
1
2
5
1
13
114
246
48
29
21
2
4
24
112
27
39
42
25
1
3
8
8
23
28
14
40
45
27
3
28
35
5
3
5
7
10
3
95
13
16
4
2
27
9
16
8
7
1
4
15
19
1
9
5
12
13
49
25
2
57
13
15
6
7
3
15
93
4
 45
77
99
8
11
55
18
47
86
102
8
39
43
27
135
50
23
26
16
59
20
45
35
7
58
51
210
36
1
28
2
10
2
44
20
12
16
40
26
19
5
43
4
3
4
 1
11
13
64
24
113
54
98
25
21
18
17
6
75
5
18
12
7
9
1
33
50
46
76
17
32
10
104
5
4
24
14
15